
<html lang="en"     class="pb-page"  data-request-id="98a04f08-07ff-4c47-951b-5fe7c5849a68"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2010.53.issue-19;article:article:10.1021/jm100736h;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5" /></meta><meta name="dc.Creator" content="Douglas F.  Burdi" /></meta><meta name="dc.Creator" content="Rachel  Hunt" /></meta><meta name="dc.Creator" content="Lei  Fan" /></meta><meta name="dc.Creator" content="Tao  Hu" /></meta><meta name="dc.Creator" content="Jun  Wang" /></meta><meta name="dc.Creator" content="Zihong  Guo" /></meta><meta name="dc.Creator" content="Zhiqiang  Huang" /></meta><meta name="dc.Creator" content="Chengde  Wu" /></meta><meta name="dc.Creator" content="Larry  Hardy" /></meta><meta name="dc.Creator" content="Michel  Detheux" /></meta><meta name="dc.Creator" content="Michael A.  Orsini" /></meta><meta name="dc.Creator" content="Maria S.  Quinton" /></meta><meta name="dc.Creator" content="Robert  Lew" /></meta><meta name="dc.Creator" content="Kerry  Spear" /></meta><meta name="dc.Description" content="A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit co..." /></meta><meta name="Description" content="A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit co..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 1, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100736h" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100736h" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100736h" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100736h" /></link>
        
    
    

<title>Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100736h" /></meta><meta property="og:title" content="Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0006.jpeg" /></meta><meta property="og:description" content="A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit compound 5a of modest potency (IC50 = 1.2 μM) was synthesized. Evaluation of structure−activity relationships (SAR) on the left-hand side of the molecule revealed a preference for a 2-substituted pyridine group linked directly to the central heterocycle. Variation of the central azolo-amine portion of the molecule revealed a preference for the [4,5-c]-oxazoloazepine scaffold, while right-hand side variants showed a preference for ortho- and meta-substituted benzene rings linked directly to the tertiary amine of the saturated heterocycle. These iterations led to the synthesis of 29b, a potent (IC50 = 16 nM) and selective negative modulator that showed good brain penetrance, high receptor occupancy, and a duration of action greater than 1 h in rat when administered intraperitoneally. Formal PK studies in rat and Rhesus monkey revealed a short half-life that was attributable to high first-pass clearance." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100736h"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100736h">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100736h&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100736h&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100736h&amp;href=/doi/10.1021/jm100736h" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 7107-7118</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1007177" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100754z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+F.++Burdi">Douglas F. Burdi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachel++Hunt">Rachel Hunt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lei++Fan">Lei Fan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Hu">Tao Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Wang">Jun Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zihong++Guo">Zihong Guo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhiqiang++Huang">Zhiqiang Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chengde++Wu">Chengde Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Larry++Hardy">Larry Hardy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Detheux">Michel Detheux</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Orsini">Michael A. Orsini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+S.++Quinton">Maria S. Quinton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Lew">Robert Lew</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kerry++Spear">Kerry Spear</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">EuroScreen SA, Rue Adrienne Bolland 47, B6041 Gosselies, Belgium</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">WuXi AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, Peoples Republic of China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Shanghai ChemPartner, Building no. 6, 998 Haki Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 1-508-357-7749. Fax: 1-508-490-5454. E-mail: <a href="/cdn-cgi/l/email-protection#25414a50424944560b475057414c655640555744464a570b464a48"><span class="__cf_email__" data-cfemail="77131802101b160459150205131e3704120705161418055914181a">[email protected]</span></a></div><div class="corresp-fn" id="fn1">⊥Current address: Galenea Corporation, 300 Technology Square, Second Floor, Cambridge, Massachusetts 02139</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100736h&amp;href=/doi/10.1021%2Fjm100736h" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 7107–7118</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 1, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 June 2010</li><li><span class="item_label"><b>Published</b> online</span>1 September 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 October 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100736h" title="DOI URL">https://doi.org/10.1021/jm100736h</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7107%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDouglas%2BF.%2BBurdi%252C%2BRachel%2BHunt%252C%2BLei%2BFan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D19%26contentID%3Djm100736h%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BNovel%2BBicyclic%2BAzole-amines%2Bas%2BNegative%2BAllosteric%2BModulators%2Bof%2BMetabotropic%2BGlutamate%2BReceptor%2B5%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7118%26publicationDate%3DOctober%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100736h"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3241</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">20</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100736h" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;F. Burdi&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;Hunt&quot;},{&quot;first_name&quot;:&quot;Lei&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zihong&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Zhiqiang&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Chengde&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Larry&quot;,&quot;last_name&quot;:&quot;Hardy&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Detheux&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Orsini&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;S. Quinton&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Lew&quot;},{&quot;first_name&quot;:&quot;Kerry&quot;,&quot;last_name&quot;:&quot;Spear&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;01&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;7107-7118&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100736h&quot;},&quot;abstract&quot;:&quot;A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit compound 5a of modest potency (IC50 = 1.2 μM) was synthesized. Evaluation of structure−activity relationships (SAR) on the left-hand side of the molecule revealed a preference for a 2-substituted pyridine group linked directly to the central heterocycle. Variation of the central azolo-amine portion of the molecule revealed a preference for the [4,5-c]-oxazoloazepine scaffold, while right-hand side variants showed a preference for ortho- and meta-substituted benzene rings linked directly to the tertiary amine of the saturated heterocycle. These iterations led to the synthesis of 29b, a potent (IC50 = 16 nM) and selective negative modulator that showed good brain penetrance, high receptor occupancy, and a duration of action greater than 1 h in rat when administered intraperitoneally. Formal PK studies in rat and Rhesus &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100736h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100736h" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100736h&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100736h" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100736h&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100736h" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100736h&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100736h&amp;href=/doi/10.1021/jm100736h" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100736h" /></input><a href="/doi/pdf/10.1021/jm100736h" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100736h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100736h%26sid%3Dliteratum%253Aachs%26pmid%3D20809633%26genre%3Darticle%26aulast%3DBurdi%26date%3D2010%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BStructure%25E2%2588%2592Activity%2BRelationships%2Bof%2BNovel%2BBicyclic%2BAzole-amines%2Bas%2BNegative%2BAllosteric%2BModulators%2Bof%2BMetabotropic%2BGlutamate%2BReceptor%2B5%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D19%26spage%3D7107%26epage%3D7118%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jmcmar.2010.53.issue-19/production/jmcmar.2010.53.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel series of diaryl bicyclic azole-amines that are potent selective negative modulators of metabotropic glutamate receptor 5 (mGluR5) were identified through rational design. An initial hit compound <b>5a</b> of modest potency (IC<sub>50</sub> = 1.2 μM) was synthesized. Evaluation of structure−activity relationships (SAR) on the left-hand side of the molecule revealed a preference for a 2-substituted pyridine group linked directly to the central heterocycle. Variation of the central azolo-amine portion of the molecule revealed a preference for the [4,5-<i>c</i>]-oxazoloazepine scaffold, while right-hand side variants showed a preference for <i>ortho</i>- and <i>meta</i>-substituted benzene rings linked directly to the tertiary amine of the saturated heterocycle. These iterations led to the synthesis of <b>29b</b>, a potent (IC<sub>50</sub> = 16 nM) and selective negative modulator that showed good brain penetrance, high receptor occupancy, and a duration of action greater than 1 h in rat when administered intraperitoneally. Formal PK studies in rat and Rhesus monkey revealed a short half-life that was attributable to high first-pass clearance.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glutamate, the major excitatory neurotransmitter in the central nervous system, binds to and activates cell surface receptors and ion channels in neurons and astrocytes. The metabotropic glutamate receptors (mGluRs<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: BINAP, 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl; BSA, bovine serum albumin; Dess−Martin reagent, 1,1,1-tris(acetyloxy)-1,1-dihydro-1,2-benziodoxol-3-(1<i>H</i>)-one; EDCI, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride; EDTA, ethylenediaminetetracetic acid; HBSS, Hank’s buffered salt solution; HOBt, hydroxybenzotriazole; ip, intraperitoneal; mGluR, metabotropic glutamate receptor; MPEP, 2-methyl-6-(phenylethynyl)pyridine; <sup>3</sup>H-mPEPy, [<sup>3</sup>H]3-methoxy-5-(pyridine-2-ylethynyl)pyridine; MTEP, 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine; PBS, phosphate buffered saline; SAR, structure−activity relationship; Xantphos, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene.</p></div>) are G protein-coupled receptors that activate intracellular second messengers when bound to glutamate. The group 1 metabotropic glutamate receptors, comprising mGluR1 and mGluR5, activate phospholipase C, leading to the mobilization of intracellular calcium.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Because of its expression in both the central nervous system and the periphery,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> modulation of mGluR5 may be useful for the treatment of both peripheral and CNS disorders. With respect to peripheral disorders, mGluR5 negative modulators have recently shown efficacy in the treatment of disorders of the gastrointestinal tract. A recent clinical trial of ADX-10059, a negative modulator of mGluR5 in gastresophageal reflux disease (GERD), met its primary end point<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> but was subsequently terminated due to liver toxicity.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> With respect to CNS disorders, negative modulators of mGluR5 have been extensively validated for the treatment of anxiety. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine (MTEP)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> has shown efficacy in a variety of animal anxiety models including stress-induced hyperthermia and fear-potentiated startle. Most recently, a phase 2 study of AFQ-056 showed efficacy in the alleviation of levodopa-induced dyskinesia in patients with Parkinson’s disease.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Following the discovery of the diaryl alkyne 2-methyl-6-(phenylethynyl)pyridine (MPEP),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> several classes of molecules have been disclosed as negative modulators of mGluR5 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Fenobam (<b>1</b>), developed as an anxiolytic of unknown mechanism in 1982,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> was serendipitously discovered to be an mGluR5 negative modulator during a high-throughput screen of a corporate library.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Other negative modulators include MTEP (<b>2</b>),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> the acetylenic octahydroindole <b>3</b>,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and the diaryl azole <b>4</b>.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Our research program has been directed toward the development of novel small-molecule negative modulators of mGluR5. The present paper describes the rational design, synthesis, biological profile, and structure−activity relationships (SAR) of a novel class of compounds containing bicyclic azole-amines as core elements.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of small molecule mGluR5 negative modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A survey of known modulators of mGluR5 suggested a pharmacophore that was most often described as two aryl groups tethered by a variety of linkers including acetylenes, azoles, and amides. We were particularly intrigued by the saturated bicyclic amine linker exemplified by <b>3</b>, and the prospect of merging this attractive, potentially ionizable feature with the biaryl azole pharmacophore exemplified by <b>4</b>. Several candidate molecules were synthesized, and oxazolopiperidine <b>5a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) emerged as a novel allosteric modulator (IC<sub>50</sub> = 1.2 μM) whose physicochemical properties (e.g., molecular weight = 302; AlogP = 2.96) presented an appropriate starting point for SAR elucidation.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of the initial hit <b>5a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of <b>5a</b> and initial analogues are described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The tetrahydrooxazolo[5,4-<i>c</i>]pyridine isomers <b>11a</b>−<b>k</b> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) were prepared in a manner similar to that shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> starting from the isomeric Cbz-protected 4-amino-3-piperidinol.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Cbz-protected amino alcohol <b>6</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> was coupled with the appropriate carboxylic acid to afford <b>7</b>. Oxidation with Dess−Martin periodinane yielded the ketone <b>8</b>, which was cyclized using phosphorus oxychloride to afford oxazolo-piperidine <b>9</b>. Deprotection of the Cbz group to afford <b>10</b> was achieved using either catalytic hydrogenation or refluxing HBr. Alkylation of the amine to form <b>5</b> with activated halides (such as 2-chloropyridine) could be realized using an organic base such as diisopropylethylamine, while couplings with less activated halides were achieved using Buchwald chemistry.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) R<sup>1</sup>COOH/EDCI; (b) Dess−Martin periodinane; (c) POCl<sub>3</sub> Δ; (d) H<sub>2</sub>/Pd(OH)<sub>2</sub> or HBr, Δ; (e) R<sup>2</sup>X/DIEA or R<sup>2</sup>X/Pd<sub>2</sub>(dba)<sub>3</sub>/NaO<i>t</i>-Bu</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Potencies of Tetrahydrooxazolopyridine Analogues as mGluR5 Negative Modulators<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0007.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">mGluR5 assay data are presented as the mean of two determinations. Assay reproducibility is monitored by the use of the mGluR5 negative modulators MPEP (IC<sub>50</sub> = 15 ± 5 nM) and <b>1</b> (IC<sub>50</sub> = 106 ± 30 nM).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Racemic mixture.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Measured using [glutamate] at 80% of its saturating concentration.</p></div></div></div><div class="NLM_p">We next turned our attention to optimization of the central azole ring. Imidazole <b>12b</b>,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> thiazole <b>13</b>,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and bridgehead imidazole <b>14</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were prepared using known procedures. The bridgehead triazolopyrazine <b>20</b> was synthesized as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Ethyl picolinimidate<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a><b>15</b> was heated with benzyl 2-hydrazinyl-2-oxoethylcarbamate<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> in refluxing ethanol, giving rise to aminomethyl-triazole <b>16</b>. Alkylation with ethyl bromoacetate afforded <b>17</b>, which was deprotected and cyclized via Pd-catalyzed hydrogenation to yield <b>18</b>. Borane/THF reduction gave piperazine <b>19</b>, which was coupled with 3-bromo-5-fluorobenzonitrile to afford <b>20</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Potencies of Tetrahydroazolopyridine Analogues<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0008.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">Z</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">0.028</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11k</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">0.054</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">34% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">52% at 10 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">0.153</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">0.346</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">mGluR5 assay data are presented as the mean of two determinations. Assay reproducibility is monitored by the use of the mGluR5 negative modulators MPEP (IC<sub>50</sub> = 15 ± 5 nM) and <b>1</b> (IC<sub>50</sub> = 106 ± 30 nM).</p></div></div></div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) benzyl 2-hydrazinyl-2-oxoethylcarbamate/EtOH/Δ; (b) ethyl bromoacetate/KO<i>t</i>-Bu/DMF; (c) H<sub>2</sub>/10%Pd/C/AcOH; (d) BH<sub>3</sub>·THF; (e) 3-bromo-5-fluorobenzonitrile/Pd<sub>2</sub>(dba)<sub>3</sub>/Xantphos/Cs<sub>2</sub>CO<sub>3</sub>.</p></p></figure><div class="NLM_p">We finally turned our attention to the fused saturated ring. To first examine the impact of ring contraction, oxazolopyrrolidine <b>21</b> was synthesized in a manner similar to the method used for <b>5k</b> in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> but starting from Cbz-protected 3-amino-4-hydroxypyrrolidine.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">The ring-expanded oxazoloazepines were synthesized as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Bromination of tosyl-protected 4-piperidinone afforded <b>22</b>, which was expanded via Eistert homologation to azepine <b>23a</b>. Hydrolysis and decarboxylation yielded <b>23b</b>, and bromide displacement with sodium azide afforded <b>24</b>. Reduction with lithium aluminum hydride afforded amino-alcohol <b>25</b> as a mixture of isomers, which were coupled with picolinic acid to afford <b>26</b>. Oxidation yielded <b>27</b>, which was cyclized to <b>28a</b> using Burgess’ reagent. Deprotection was achieved using HBr to yield <b>28b</b>; Buchwald coupling with the appropriate bromide afforded nitriles <b>29a</b> and <b>29b</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Br<sub>2</sub>/DCM; (b) ethyl diazoacetate/BF<sub>3</sub>·Et<sub>2</sub>O; (c) 3N HCl/Δ; (d) NaN<sub>3</sub>/DMF/AcOH; (e) LAH/THF; (f) picolinic acid/EDCI/DCM; (g) Dess−Martin reagent/DCM; (h) Burgess' Reagent, THF, Δ; (i) 48% HBr/Δ; (j) 3-bromo-5-f luorobenzonitrile or 3-bromobenzonitrile/Pd<sub>2</sub>(dba)<sub>3</sub>/NaO<i>t</i>-Bu</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our initial efforts began with a broad survey of the SAR in order to define the minimum pharmacophore and a path forward. Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> shows a representative SAR of a series of tetrahydrooxazolo[4,5-<i>c</i>]pyridines (<b>5a</b>−<b>k</b>) and the isomeric tetrahydrooxazolo[5,4-<i>c</i>]pyridines (<b>11a</b>−<b>k</b>). The IC<sub>50</sub> values were measured in cells inducibly expressing the recombinant human receptor, using a luminescence-based calcium mobilization assay.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">As mentioned earlier, the initial hit <b>5a</b> showed modest potency (IC<sub>50</sub> = 1.2 μM) that was comparable with its isomeric counterpart <b>11a</b> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Replacement of the phenyl ring on the left-hand side with a 2-pyridyl group as seen in <b>5b</b> and <b>11b</b> (IC<sub>50</sub>s = 0.11 and 0.64 μM, respectively) improved potency by an order of magnitude. Alkyl group replacements, as exemplified by <b>5c</b> and <b>11c</b>, eliminated activity. Cycloakyl substituents, as shown in <b>11d</b> (79% at 10 μM), retained some potency but were clearly inferior to their 2-pyridyl counterparts. Saturation of the 2-pyridyl substituent afforded <b>11h</b>, prepared as a racemic mixture, which showed modest, but greatly reduced potency relative to its unsaturated counterpart. Interestingly, the 3- and 4-pyridyl isomers <b>5j</b> and <b>11j</b> were inactive relative to their 2-pyridyl counterparts <b>5i</b> and <b>11i</b>; these stark contrasts in potencies served as testimony to the steepness of the SAR that we encountered on this side of the molecule. We concluded from these initial studies that a 2-pyridyl substituent was preferred on the left-hand side of the molecule, and this substituent was carried into the next phase of SAR development.</div><div class="NLM_p">We next turned our attention to the right-hand side of the molecule, where preference for substituted aryl rings was quickly established. Recapitulation of the carbamate functionality in <b>3</b>, exemplified by the synthesis of <b>5f</b>, led to a loss of activity. Saturation of the phenyl substituent in <b>5g</b> (IC<sub>50</sub> = 0.33 μM) led to <b>5d</b>, which was devoid of activity, as was the saturated amine <b>5h</b>. Alkyl substituents, exemplified by the isopropyl-substituted <b>5e</b>, were inactive. The linker region between the central and terminal rings did not tolerate homologation. Sulfonamides such as <b>11f</b> were inactive; homologation of the linker in <b>11i</b> gave rise to benzylic amine <b>11g</b>, which showed a steep drop in potency. Finally, insertion of a carbonyl group in the linker region, as exemplified by carboxamide <b>11e</b> (IC<sub>50</sub> = 2.6 μM), gave compounds with greatly reduced potency relative to their lower homologues.</div><div class="NLM_p">To complete the initial survey of SAR, we addressed the preference for oxazole isomers in the central ring. A comparison of oxazole isomers <b>5b</b> (IC<sub>50</sub> = 0.11 μM) and <b>11b</b> (IC<sub>50</sub> = 0.64 μM) and isomers <b>5i</b> (IC<sub>50</sub> = 0.06 μM) and <b>11i</b> (IC<sub>50</sub> = 0.29 μM) revealed a small but consistent preference for the [4,5-<i>c</i>] isomer. This trend was further confirmed by the addition of a fluorine substituent to the 3-position of the benzonitrile, which afforded <b>5k</b> (IC<sub>50</sub> = 0.028 μM) and <b>11k</b> (IC<sub>50</sub> = 0.054 μM). From these initial efforts, compound <b>5k</b> emerged as a lead compound and was selected for further optimization.</div><div class="NLM_p">The SAR of the core-modified tetrahydroazolopyridine analogues is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Compound <b>5k</b>, which depicts the favored [4,5-<i>c</i>] orientation of the oxazole, and [5,4-<i>c</i>]-oxazole <b>11k</b>, are included for comparison. The profound structural sensitivity of the core heterocycle is evidenced by the dramatic loss of potency seen in imidazole <b>12b</b> and thiazole <b>13</b>. Although some activity was retained in the isomeric imidazopiperazine <b>14</b> and triazolopiperazine <b>20</b>, these analogues were inferior to <b>5k</b> by nearly an order of magnitude. We concluded that the substitution and orientation evoked by [4,5-<i>c</i>]-oxazole <b>5k</b> was optimal for activity.</div><div class="NLM_p">The in vitro potencies of saturated ring variants (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) show a trend to higher potency with increased ring size, with similar potencies seen in the six- and seven-membered rings. Homologation of pyrrolidine <b>21</b> to piperidine <b>5i</b> led to a 4-fold increase in potency; substitution of fluorine for hydrogen at the <i>meta</i>-position, resulting in <b>5k</b>, gave the expected boost in potency. Addition of a second methylene unit led to azepines <b>29a</b> and <b>29b</b>, where we were pleased to achieve an in vitro potency of 16 nM. On the basis of their in vitro potencies, <b>29b</b> and its six-membered ring counterpart <b>5k</b> were selected for further study and characterization.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. The Effect of Saturated Ring Size on in Vitro Potencies<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0009.gif" alt="" id="fx4" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.219</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.057</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.028</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29a</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.065</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">mGluR5 assay data are presented as the mean of two determinations. Assay reproducibility was monitored by the use of the mGluR5 negative modulators MPEP (IC<sub>50</sub> = 15 ± 5 nM) and <b>1</b> (IC<sub>50</sub> = 106 ± 30 nM).</p></div></div></div><div class="NLM_p">To identify any off-target activities, <b>5k</b> and <b>29b</b> were profiled extensively against a battery of in vitro assays including mGluR1 at test compound concentrations of 10 μM. Of 55 receptors screened (Cerep ExpresSProfile), only a weak, but detectable activity at the κ-opioid receptor (77%I @ 10 μM) was detected for <b>29b</b>.</div><div class="NLM_p">Binding studies in vitro showed that both <b>5k</b> and <b>29b</b> interact with the allosteric modulation site of mGluR5 originally identified as the binding site of MPEP (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> For these two compounds and several analogues tested (additional data not shown), binding affinities for this site with rat brain and human recombinant mGluR5 were very closely correlated with the potencies for functional inhibition of recombinant human mGluR5.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Receptor Occupancies and Exposures for mGluR5 Negative Modulators <b>5k</b> and <b>29b</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">human mGluR5 IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">rat mGluR5 K<sub>i</sub> (nM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">%RO<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char="±">plasma levels (nM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char="±">brain levels (nM)<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">RO<sub>50</sub> (mpk)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char="±">2486 ± 959</td><td class="colsep0 rowsep0" align="char" char="±">1293 ± 431</td><td class="colsep0 rowsep0" align="left">>30<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29b</b></td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="char" char=".">17</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char="±">1433 ± 494</td><td class="colsep0 rowsep0" align="char" char="±">1096 ± 216</td><td class="colsep0 rowsep0" align="left">0.9<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">mGluR5 assay data are presented as the mean of two determinations. Assay reproducibility is monitored by the use of the mGluR5 negative modulators MPEP (IC<sub>50</sub> = 15 ± 5 nM) and <b>1</b> (IC<sub>50</sub> = 106 ± 30 nM).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Binding assay for displacement of [<sup>3</sup>H]-MPEP from rat cortical membranes in vitro, represented as the mean of two determinations. Assay reproducibility is monitored by the use of the mGluR5 negative modulator MPEP (<i>K</i><sub>i</sub> = 10 ± 1 nM)</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Receptor occupancy in vivo following 3 mpk dose administered ip.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Average of four rats/cohort.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Dose−response measurements conducted at 0.3, 1, 3, 10, and 30 mpk po.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Dose−response measurements conducted at 0.3, 1, 3, 10, and 30 mpk ip.</p></div></div></div><div class="NLM_p">The good correlation observed between binding affinity and functional potency prompted us to employ a single-dose receptor occupancy assay in order to rapidly assess brain penetrance and in vivo affinity of molecules of interest. Briefly, male Sprague−Dawley rats were dosed at time zero with the test compound. After 60 min, <sup>3</sup>H-mPEPy was administered via tail-vein injection, and the animals were sacrificed 2 min later. Binding of the test compound to mGluR5 receptors in striatum and cerebellum from dose rats was quantified by measuring decreases in <sup>3</sup>H-mPEPy bound, which was measured by a digital radiographic imager. Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> contains a detailed comparison of <b>5k</b> and <b>29b</b>. Both compounds showed good brain penetration and similar brain/plasma ratios. Azepine <b>29b</b> exhibited an occupancy ED<sub>50</sub> of 0.9 mg/kg when administered intraperitoneally.</div><div class="NLM_p">Encouraged by the results for <b>29b</b>, we determined the duration of occupancy following a 3 mpk ip dose; the results are displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. The rapid brain penetrance of <b>29b</b> is evidenced by the 85% receptor occupancy recorded at 30 min postdose. This level of occupancy persisted at 1 h, declined to 55% occupancy at 2 h, and ultimately returned to baseline 24 h postdose. The plasma pharmacokinetics of <b>29b</b> were also characterized to allow a more detailed comparison with the duration of action.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Duration of occupancy of <b>29b</b> in rat following a 3 mpk ip dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmacokinetic parameters for <b>29b</b> in both rat and monkey, shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, were disappointing. Despite its reasonable oral bioavailability in rat (30%), <b>29b</b> exhibited a half-life of less than 1 h. The short half-life persisted in higher species (monkey) and was likely the major contributor to the poor bioavailability (10%) seen in this species. A high rate of hepatic microsomal oxidation was identified as the culprit in both species (data not shown), and a major campaign was undertaken to identify and block the site(s) of metabolism. The results of these efforts will be reported in due course.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of <b>29b</b> in Rat<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> and Monkey<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species (dose)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0−<i>t</i></sub> (μM·h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±"><i>V</i><sub>d</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="±">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat (2 mpk iv)</td><td class="colsep0 rowsep0" align="char" char="±">2.26 ± 0.69</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.18</td><td class="colsep0 rowsep0" align="char" char="±">2.38 ± 0.50</td><td class="colsep0 rowsep0" align="char" char="±">2.79 ± 0.88</td><td class="colsep0 rowsep0" align="char" char="±">5.25 ± 1.53</td><td class="colsep0 rowsep0" align="char" char=".">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat (2 mpk po)</td><td class="colsep0 rowsep0" align="char" char="±">0.70 ± 0.25</td><td class="colsep0 rowsep0" align="char" char="±">0.77 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">N/A</td><td class="colsep0 rowsep0" align="char" char="±">N/A</td><td class="colsep0 rowsep0" align="char" char="±">0.62 ± 0.20</td><td class="colsep0 rowsep0" align="char" char=".">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat (10 mpk po)</td><td class="colsep0 rowsep0" align="char" char="±">3.36 ± 1.39</td><td class="colsep0 rowsep0" align="char" char="±">0.91 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">N/A</td><td class="colsep0 rowsep0" align="char" char="±">N/A</td><td class="colsep0 rowsep0" align="char" char="±">2.73 ± 1.04</td><td class="colsep0 rowsep0" align="char" char=".">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey (1 mpk iv)</td><td class="colsep0 rowsep0" align="char" char="±">3.06 ± 0.48</td><td class="colsep0 rowsep0" align="char" char="±">0.67 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">0.95 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">0.98 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">5.08 ± 1.31</td><td class="colsep0 rowsep0" align="char" char=".">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey (1 mpk po)</td><td class="colsep0 rowsep0" align="char" char="±">0.28 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.19</td><td class="colsep0 rowsep0" align="char" char="±">N/A</td><td class="colsep0 rowsep0" align="char" char="±">N/A</td><td class="colsep0 rowsep0" align="char" char="±">0.21 ± 0.06</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Male Sprague−Dawley rats (three animals per cohort).</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Male Rhesus monkeys (three animals per cohort).</p></div></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06311" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06311" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel set of diaryl bicyclic amines have been identified. The substituent effects on the terminal aryl rings, the central azole ring, and the fused saturated ring have been elucidated and have resulted in oxazolo-azepine <b>29b</b>. This molecule displays excellent in vitro potency and selectivity, good brain penetration, and robust receptor occupancy in rodent. Despite its acceptable oral bioavailability in rodent, its half-life in both rodent and primate is short. In view of recent reports highlighting the need for high sustained receptor occupancies in order to achieve efficacy in animal models of levodopa-induced dyskinesia,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> the short half-life seen in <b>29b</b> represents a significant hurdle to development, and a series of corrective actions have been undertaken to impede first-pass clearance via metabolic blockade.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46302" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46302" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were purchased from Aldrich and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen atmosphere. Compounds were purified using preparative thin layer chromatography or medium pressure liquid chromatography on a CombiFlash Companion (Teledyne Isco) with RediSep normal-phase silica gel (230−400 mesh) and UV detection at 254 nm. The purity of all final compounds was determined to be ≥95% by HPLC unless otherwise indicated. The purities of intermediates and final compounds were determined by integration of the UV signal obtained by analytical LC/MS on an Agilent 1100 series instrument equipped with a diode array detector and a Waters Micromass spectrometer. <sup>1</sup>H NMR data were determined with a Varian 400 MHz spectrometer at ambient temperature and are reported in the form of delta (δ) values given in parts per million (ppm) relative to tetramethylsilane (TMS) as an internal standard. Conventional abbreviations used for signal shape are: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 2-(2-Phenyl-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)nicotinonitrile (<b>5a</b>)</h3><div class="NLM_p last">2-Phenyl-4,5,6,7-tetrahydro[1,3]oxazolo[4,5-<i>c</i>]pyridine hydrochloride (purchased from Anichem) (200 mg, 0.84 mmol), 2-chloro-3-pyridine-carbonitrile (176 mg, 1.27 mmol), and DIEA (218 mg, 1.69 mmol) were combined in DMF (1.5 mL) and heated under microwave at 100 °C for 40 min. The solvent was concentrated and removed under vacuum. The residue was then purified by silica gel column (EtOAc (10%MeOH)/hexanes), followed by HPLC purification to give a white solid (62 mg, 24%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.36 (dd, <i>J</i><sub>1</sub> = 5.2 Hz, <i>J</i><sub>2</sub> = 1.9 Hz, 1H), 8.01 (m, 2H), 7.83 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 1.8 Hz, 1H), 7.45 (m, 3H), 6.78 (dd, <i>J</i><sub>1</sub> = 7.8 Hz, <i>J</i><sub>2</sub> = 4.8 Hz, 1H), 4.73 (s, 2H), 4.10 (t, <i>J</i> = 5.4 Hz, 2H), 3.09 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 303 (M + H)<sup>+</sup>. HPLC purity: 98%.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 2-(2-(Pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)nicotinonitrile (<b>5b</b>)</h3><div class="NLM_p last">To a solution of 2-pyridin-2-yl-4,5,6,7-tetrahydro-oxazolo[4,5-<i>c</i>]-pyridine (60 mg, 0.3 mmol) and DIEA (77 mg, 0.6 mmol) in DMF (2 mL) was added 2-chloro-nicotinonitrile (62 mg, 0.45 mmol). The mixture was heated to 100 °C overnight. The mixture was partitioned between EtOAc and H<sub>2</sub>O, and the organic layer dried over MgSO<sub>4</sub>. The crude product was purified by preparative HPLC to afford 2-(2-pyridin-2-yl-6,7-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]pyridin-5-yl)-nicotinonitrile (1.5 mg, 2%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.69 (t, <i>J</i> = 1.6 Hz, 1H), 8.31 (dd, <i>J</i><sub>1</sub> = 4.8 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 8.08 (d, <i>J</i> = 8.0 Hz, 1H), 7.84 (m, 1H), 7.76 (dd, <i>J</i><sub>1</sub> = 7.6 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 7.35 (t, <i>J</i> = 7.2 Hz, 1H), 6.76 (dd, <i>J</i><sub>1</sub> = 7.6 Hz, <i>J</i><sub>2</sub> = 4.4 Hz, 1H), 4.69 (s, 2H), 4.06 (t, <i>J</i> = 5.2 Hz, 2H), 3.08 (t, <i>J</i> = 5.2 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 304 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 2-(2-Methyl-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)nicotinonitrile (<b>5c</b>)</h3><div class="NLM_p last">2-Methyl-4,5,6,7-tetrahydro-oxazolo[4,5-<i>c</i>]pyridine hydrochloride (purchased from Anichem) (200 mg, 1.14 mmol), 2-chloro-3-pyridine-carbonitrile (317 mg, 2.29 mmol), and DIEA (444 mg, 3.43 mmol) were combined in DMF (1.0 mL) and heated under in a microwave reactor at 160 °C for 1.5 h. The solvent was removed under vacuum, and the residue was purified by silica gel column (EtOAc (10%MeOH)/hexanes) to give a yellow oil (245 mg, 89%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.34 (dd, <i>J</i><sub>1</sub> = 4.8 Hz, <i>J</i><sub>2</sub> = 2 Hz, 1H), 7.78 (dd, <i>J</i><sub>1</sub> = 7.6 Hz, <i>J</i><sub>2</sub> = 2.2 Hz, 1H), 6.76 (dd, <i>J</i><sub>1</sub> = 7.6 Hz, <i>J</i><sub>2</sub> = 4.8 Hz, 1H), 4.59 (m, 2H), 4.02 (t, <i>J</i> = 5.4 Hz, 2H), 2.95 (m, 2H), 2.44 (s, 3H). LC/MS: <i>m</i>/<i>e</i> = 241 (M + H)<sup>+</sup>. HPLC purity: 95%.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 5-Cyclohexyl-2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (<b>5d</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (100 mg, 0.50 mmol) in DCM (10 mL) was added cyclohexanone (50 mg, 0.50 mmol) and acetic acid (90 mg, 1.5 mmol). After stirring for 20 min, NaBH(OAc)<sub>3</sub> (420 mg, 2.00 mmol) was added and the mixture was stirred for an additional 2 h. The solvent was removed in vacuo, and the residue was purified using reverse phase chromatography to afford the desired product (90 mg, 60%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.69 (m,1H), 8.07 (d, <i>J</i> = 8.0 Hz, 1H), 7.79 (m, 1H), 7.32 (m, 1H), 3.70 (m, 2H), 2.97 (m, 2H), 2.87 (m, 2H), 2.58 (m, 1H), 1.93 (m, 2H), 1.83 (m, 2H), 1.68 (m, 1H), 1.31 (m, 4H), 1.16 (m, 1H). LC/MS: <i>m</i>/<i>e</i> = 284 (M + H)<sup>+</sup>. HPLC purity: 98%.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 5-Isopropyl-2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (<b>5e</b>)</h3><div class="NLM_p last">2-(Pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (200 mg, 0.71 mmol), sodium cyanoborohydride (45 mg, 0.71 mmol), acetone (2 mL), and acetic acid (2 drops) were combined in DCM (2 mL) and stirred at room temperature for 2 days. Water (10 mL) was added, and the mixture was extracted with EtOAc. The aqueous layer was concentrated in vacuo to a volume of 1.5 mL and purified by reverse phase chromatography to give a yellow oil (11 mg, 7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.68 (d, 1H), 8.06 (d, <i>J</i> = 8.0 Hz, 1H), 7.78 (t, <i>J</i> = 8.0 Hz, 1H), 7.32 (m, 1H), 3.65 (s, 2H), 3.02 (m,1H), 2.88 (m, 4H), 1.15 (d, 6H). LC/MS: <i>m</i>/<i>e</i> = 244 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Methyl 2-(Pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridine-5(4<i>H</i>)-carboxylate (<b>5f</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (100 mg, 0.50 mmol) in THF (10 mL) was added methyl carbonochloridate (50 mg, 0.50 mmol) and triethylamine (100 mg, 1.00 mmol). The mixture was stirred at room temperature for 2 h. The solvent was evaporated in vacuo, and the residue was purified using reverse phase chromatography to give the desired product (75 mg, 60%) as a white solid. ESI (<i>m</i>/<i>e</i>) (M + H)<sup>+</sup>: 260.0. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.69 (m, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.84 (m, 1H), 7.27 (m, 1H), 4.55 (m, 2H), 3.90 (m, 2H), 3.76 (s, 3H), 2.86 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 260 (M + H)<sup>+</sup>. HPLC purity: 97%.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 5-Phenyl-2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (<b>5g</b>)</h3><div class="NLM_p last">2-(Pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (202 mg, 0.72 mmol), tris (dibenzylideneacetone)dipalladium(0) (46 mg, 0.05 mmol), 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (111 mg, 0.18 mmol), and bromobenzene (246 mg, 1.57 mmol) were combined in toluene (4 mL). The mixture was flushed with nitrogen, and sodium <i>t</i>-butoxide (275 mg, 2.86 mmol) was added. The mixture was flushed again with nitrogen and then heated at 80 °C for 24 h. The reaction was filtered through Celite, and the solvent evaporated in vacuo. The crude material was purified by reverse phase chromatography (NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile) to give a brown solid (70 mg, 35%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.71 (s, 1H), 7.98 (d, <i>J</i> = 8.0 Hz, 1H), 7.81 (t, <i>J</i> = 8.0 Hz, 1H), 7.40 (t, 1H), 7.26−7.32 (m, 2H), 7.00 (d, <i>J</i> = 8.0 Hz, 2H), 6.88 (t, <i>J</i> = 8.0 Hz, 1H), 4.30 (s, 2H), 3.70 (s, 2H), 2.97 (s, 2H). LC/MS: <i>m</i>/<i>e</i> = 278 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 5-Piperidin-4-yl-2-pyridin-2-yl-4,5,6,7-tetrahydro- oxazolo[4,5-<i>c</i>]pyridine (<b>5h</b>)</h3><div class="NLM_p">To a solution of 2-pyridin-2-yl-4,5,6,7-tetrahydro-oxazolo[4,5-<i>c</i>]pyridine (200 mg, 1 mmol) in MeOH (15 mL) was added NaBH<sub>3</sub>CN (188 mg, 3 mmol) at 0 °C. After stirring for 10 min, a solution of 4-oxo-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (597 mg, 03 mmol) in MeOH (5 mL) was added to the above mixture. The reaction was stirred for 10 h at room temperature. The reaction was concentrated to dryness and partitioned between EtOAc and H<sub>2</sub>O. The organic layer was separated and dried over Na<sub>2</sub>SO<sub>4</sub>. Concentration afforded crude product, which was purified by prep-TLC to afford 4-(2-pyridin-2-yl-6,7-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]pyridin-5-yl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (87 mg, 20%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.63 (d, <i>J</i> = 4.4 Hz, 1H), 7.99 (d, <i>J</i> = 4.0 Hz, 1H), 7.71 (t, <i>J</i> = 2.0 Hz, 1H), 7.27 (t, <i>J</i> = 4.8 Hz, 1H), 4.15 (m, 2H), 3.66 (s, 2H), 2.93 (m, 2H), 2.83−2.90 (m, 2H), 2.62−2.70 (m, 3H), 1.83 (m, 2H), 1.40 (s, 9H). HPLC purity: 100%.</div><div class="NLM_p">To a solution of 4-(2-pyridin-2-yl-6,7-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]pyridin-5-yl)-piperidine-1- carboxylic acid <i>tert</i>-butyl ester (50 mg, 0.13 mmol) in DCM (2 mL) was added TFA (3 mL) at room temperature The mixture was stirred for 4 h at rt. The solution was concentrated to give the product 5-piperidin-4-yl-2-pyridin-2-yl-4,5,6,7-tetrahydro-oxazolo[4,5-<i>c</i>]pyridine <b>5h</b> (40 mg, 71%) as its TFA salt.</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub> + MeOD)</h4><div class="NLM_p last">δ 8.58 (s, 1H), 7.97 (d, <i>J</i> = 8.0 Hz, 1H), 7.80 (t, <i>J</i> = 7.2 Hz, 1H), 7.30−7.37 (m, 1H), 4.29 (s, 2H), 3.72 (m, 1H), 3.60 (s, 2H), 3.45 (d, <i>J</i> = 12.8 Hz, 2H), 3.23 (d, <i>J</i> = 1.6 Hz, 1H), 3.16 (s, 2H), 3.01 (t, <i>J</i> = 12.8 Hz, 2H), 2.26 (d, <i>J</i> = 11.6, 2H), 2.10−2.20 (m, 2H).. LC/MS: <i>m</i>/<i>e</i> = 285 (M + H)<sup>+</sup>. HPLC purity: 99%.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 3-(2-(Pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>5i</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[4,5-<i>c</i>]pyridine (20 mg, 0.1 mmol) in toluene (2 mL) was added 3-bromobenzonitrile (27 mg, 0.15 mmol), Cs<sub>2</sub>CO<sub>3</sub> (65 mg, 0.2 mmol), Pd(OAc)<sub>2</sub> (1 mg, cat.), and Xantphos (2 mg, cat.). The reaction was heated to 100 °C and stirred overnight. The mixture was dissolved in MeOH and filtered. The filtrate was concentrated, and the residue was purified by preparative HPLC to afford 3-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (5 mg, 17%) as a yellow solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>): δ 8.65 (d, <i>J</i> = 4.4 Hz, 1H), 8.15 (d, <i>J</i> = 8.0 Hz, 1H), 8.05 (t, <i>J</i> = 6.0 Hz, 1H), 7.50−7.60 (m, 1H), 7.30−7.41 (m, 3H), 7.11 (d, <i>J</i> = 5.2 Hz, 1H), 4.31 (s, 2H), 3.80 (t, <i>J</i> = 5.6 Hz, 2H), 2.99 (t, <i>J</i> = 5.6 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 303 (M + H)<sup>+</sup>. HPLC purity: 96%</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 3-(2-(Pyridin-4-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>5j</b>)</h3><div class="NLM_p last">The title compound was prepared via the procedure used for <b>5i</b>, substituting pyridine-4-carboxylic acid for picolinic acid. Preparative HPLC afforded 3-(2-(pyridin-4-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (10 mg, 13%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.78 (d, <i>J</i> = 6.4 Hz, 2H), 8.12 (d, <i>J</i> = 6.4 Hz, 2H), 7.28−7.33 (m, 1H), 7.07−7.13 (m, 3H), 4.29 (s, 2H), 3.72 (t, <i>J</i> = 5.6 Hz, 2H), 2.93−3.00 (t, <i>J</i> = 5.2 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 303 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 3-Fluoro-5-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>5k</b>)</h3><div class="NLM_p last">The title compound was prepared via the procedure used for <b>5i</b>, substituting 3-bromo-5-fluorobenzonitrile for 3-bromobenzonitrile. Preparative HPLC afforded 3-fluoro-5-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (30 mg, 18%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.74 (d, 1H), 8.12 (m, 1H), 7.91−7.96 (m, 1H), 7.45−7.48 (m, 1H), 6.91 (s, 1H), 6.72−6.79 (m, 2H), 4.29 (s, 2H), 3.71 (m, 2H), 2.94 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 321 (M + H)<sup>+</sup>. HPLC purity: 98%.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 4-Hydroxy-3-[(pyridine-2-carbonyl)-amino]-piperidine-1-carboxylic acid benzyl ester (<b>7</b>)</h3><div class="NLM_p last">To a solution of pyridine-2-carboxylic acid (492 mg, 4 mmol) and TEA (1.21 g, 12 mmol) in DCM (25 mL) was added EDCI (1.53 g, 8 mmol) and HOBt (1.08 g, 8 mmol). (<i>±</i>)-<i>trans</i>-3-Amino-4-hydroxy-piperidine-1-carboxylic acid benzyl ester <b>6</b><a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (1.00 g, 4 mmol) in DCM (5 mL) was added to the above mixture, and the reaction was stirred overnight at room temperature. The mixture was partitioned between DCM and water, and the organic layer was washed with aq NaHCO<sub>3</sub>, 1N HCl solution, and brine. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to afford 4-hydroxy-3-[(pyridine-2-carbonyl)-amino]-piperidine-1-carboxylic acid benzyl ester (1.2 g, 84%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.46 (m, 1H), 8.12 (m, 2H), 7.80 (m, 1H), 7.38 (m, 1H), 7.29 (m, 4H), 5.06 (m, 2H), 4.16 (m, 1H), 3.88 (m, 2H), 3.76 (m, 1H), 3.12 (m, 2H), 1.98 (m, 2H), 1.58 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 356 (M + H)<sup>+</sup>. HPLC purity: 94%.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-Oxo-3-[(pyridine-2-carbonyl)-amino]-piperidine-1-carboxylic Acid Benzyl Ester (<b>8</b>)</h3><div class="NLM_p last">To a solution of 4-hydroxy-3-[(pyridine-2-carbonyl)-amino]-piperidine-1-carboxylic acid benzyl ester (500 mg, 1.4 mmol) in DCM (10 mL) was added Dess−Martin reagent (656 mg, 2.8 mmol). The mixture was stirred overnight at room temperature. The reaction was partitioned between 0.5N NaOH and DCM. The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to afford crude product. Purification by preparative TLC (PT/EtOAc = 1:1) afforded 4-oxo-3-[(pyridine-2-carbonyl)-amino]-piperidine-1-carboxylic acid benzyl ester (400 mg, 81%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.54 (m, 1H), 8.14 (m, 1H), 7.80 (m, 1H), 7.22−7.40 (m, 6H), 5.10−5.30 (m, 2H), 4.96 (m, 1H), 4.69 (m, 1H), 4.48 (m, 1H), 4.48 (m, 1H), 2.85 (m, 1H), 2.62 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 354 (M + H)<sup>+</sup>. HPLC purity: 95%.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-Pyridin-2-yl-6,7-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]pyridine-5-carboxylic acid benzyl ester (<b>9</b>)</h3><div class="NLM_p last">To a solution of POCl<sub>3</sub> (767 mg, 2.5 mmol) in dioxane (10 mL), 4-oxo-3-[(pyridine-2-carbonyl)-amino]-piperidine-1-carboxylic acid benzyl ester (0.9 g, 2.5 mmol) in dioxane (10 mL) was added. The reaction mixture was heated to reflux and stirred for 3 h. The mixture was quenched into water and extracted with EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was concentrated, and the residue was purified by silica gel chromatography (PE:EtOAc = 1:1) to afford 2-pyridin-2-yl-6,7-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]pyridine-5-carboxylic acid benzyl ester (430 mg, 51%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.69 (m, 1H), 8.08 (m, 1H), 7.79 (t, <i>J</i> = 6.0 Hz, 1H), 7.28 (m, 6H), 5.20 (s, 2H), 4.60 (s, 2H), 3.86 (m, 2H), 2.88 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 336 (M + H)<sup>+</sup>. HPLC purity: 98%.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-Pyridin-2-yl-4,5,6,7-tetrahydro-oxazolo[4,5-<i>c</i>]pyridine (<b>10</b>)</h3><div class="NLM_p last">To a solution of 2-pyridin-2-yl-6,7-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]pyridine-5-carboxylic acid benzyl ester (430 mg, 1.28 mmol) in MeOH (3 mL) was added Pd(OH)<sub>2</sub> (20 mg). The mixture was stirred at room temperature under H<sub>2</sub> for 0.5 h. The mixture was filtered and the filtrate was concentrated to afford 2-pyridin-2-yl-4,5,6,7-tetrahydro-oxazolo[4,5-<i>c</i>]-pyridine (230 mg, 89%). <sup>1</sup>H NMR: (400 MHz, CDCl<sub>3</sub>): δ 8.72 (d, <i>J</i> = 4.4 Hz, 1H), 8.08 (d, <i>J</i> = 8.0 Hz, 1H), 7.80 (t, <i>J</i> = 6.0 Hz, 1H), 7.34 (m, 1H), 3.84 (m, 1H), 3.68 (s, 1H), 3.49 (m, 1H), 3.14 (m, 1H), 3.06 (m, 1H), 2.86 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 202 (M + H)<sup>+</sup>. HPLC purity: 95%.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(2-Phenyl-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)nicotinonitrile (<b>11a</b>)</h3><div class="NLM_p last">2-Phenyl-4,5,6,7-tetrahydro-oxazolo[5,4-<i>c</i>]pyridine hydrochloride (purchased from Anichem) (200 mg, 0.84 mmol), 2-chloro-3-pyridine-carbonitrile (234 mg, 1.69 mmol), and DIEA (327 mg, 2.53 mmol) were combined in DMF (1.0 mL) and heated under microwaves at 160 °C for 1.5 h. The solvent was concentrated and removed under vacuum. The residue was then purified by silica gel column (EtOAc (10% MeOH)/hexanes), followed by recrystallization in ethanol to give a white solid (54 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.37 (dd, <i>J</i><sub>1</sub> = 5.0 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 8.02 (m, 2H), 7.80 (dd, <i>J</i><sub>1</sub> = 8.0 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 7.38−7.46 (m, 3H), 6.78 (dd, <i>J</i><sub>1</sub> = 7.4 Hz, <i>J</i><sub>2</sub> = 5.2 Hz, 1H), 4.73 (s, 2H), 4.10 (t, <i>J</i> = 5.6 Hz, 2H), 3.09 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 303 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(2-(Pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)nicotinonitrile (<b>11b</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine (100 mg, 0.5 mmol) in DMF (5 mL) was added 2-chloronicotinonitrile (140 mg, 1 mmol) and DIEA (140 mg, 1 mmol). The mixture was heated to 100 °C and stirred for 6 h. The mixture was cooled to room temperature, poured into water, and extracted with EtOAc. The organic phase was concentrated, and the residue was purified by preparative TLC to afford 2-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)nicotinonitrile (20 mg, 13%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.65 (s, 1H); 8.30 (dd, <i>J</i><sub>1</sub> = 5.2 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 1H), 8.07 (d, <i>J</i> = 7.6 Hz, 1H), 7.78 (m, 2H), 7.30 (t, <i>J</i> = 6.0 Hz, 1H), 6.75 (q, <i>J</i> = 4.8 Hz, 1H), 4.81 (s, 2H), 4.03 (t, <i>J</i> = 5.6 Hz, 2H), 2.92 (t, <i>J</i> = 5.2 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 304 (M + H)<sup>+</sup>. HPLC purity: 94%.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(2-Isopropyl-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>11c</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner similar to <b>11i</b> starting from isobutyric acid and (<i>±</i>)-<i>trans</i>-4-amino-3-hydroxy-piperidine-1-carboxylic acid benzyl ester. Purification using reverse phase chromatography afforded the desired compound (58 mg, 58%) as a yellowish oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.35 (m, 1H), 7.13 (m, 3H), 4.29 (m, 2H), 3.64 (m, 2H), 3.08 (m, 1H), 2.73 (m, 2H), 1.35 (d, <i>J</i> = 7.2 Hz, 6H). LC/MS: <i>m</i>/<i>e</i> = 286 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 3-(2-cyclohexyl-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>11d</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner similar to <b>11i</b> starting from cyclohexanecarboxylic acid and (<i>±</i>)-<i>trans</i>-4-amino-3-hydroxy-piperidine-1-carboxylic acid benzyl ester. Purification using reverse phase chromatography afforded the desired compound (80 mg, 53%) as colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.34 (m, 1H), 7.10 (m, 3H), 4.29 (m, 2H), 3.64 (m, 2H), 2.73 (m, 3H), 2.07 (m, 2H), 1.83 (m, 2H), 1.55−1.75 (m, 5H), 1.33 (m, 3H). LC/MS: <i>m</i>/<i>e</i> = 308 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 3-(2-(Pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine-5-carbonyl)benzonitrile (<b>11e</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine (50 mg, 0.248 mmol) in DCM (5 mL) was added 3-cyanobenzoyl chloride (45 mg, 0.273 mmol) and TEA (38 mg, 0.372 mmol) in DCM. The mixture was stirred at room temperature for 1 h. The reaction was concentrated and purified by preparative TLC to afford 3-(2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine-5-carbonyl)benzonitrile (13 mg, 14%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.65 (s, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 1H), 7.78−7.75 (m, 1H), 7.72−7.70 (m, 2H), 7.65 (d, <i>J</i> = 8.0 Hz, 1H), 7.54 (t, <i>J</i> = 8.0 Hz, 1H), 7.30 (dd, <i>J</i><sub>1</sub> = 6.8 Hz, <i>J</i><sub>2</sub> = 4.4 Hz, 1H), 4.85 (s, 2H), 3.64 (s, 2H), 2.74 (s, 2H). LC/MS: <i>m</i>/<i>e</i> = 331 (M + H)<sup>+</sup>. HPLC purity: 92%.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(2-(Pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-ylsulfonyl)benzonitrile (<b>11f</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine (60 mg, 0.3 mmol) in dry DCM (10 mL) was added TEA (42 μL, 0.3 mmol) and 3-cyanobenzene-1-sulfonyl chloride (75 mg, 0.37 mmol). The reaction was stirred overnight at room temperature. The solvent was removed in vacuo and the residue purified by prep-TLC to afford 3-(2-(pyridin-2-yl)- 6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-ylsulfonyl)benzonitrile (10 mg, 11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.55 (d, <i>J</i> = 5.2 Hz, 1H), 8.05 (s, 1H), 7.98 (d, <i>J</i> = 8.0 Hz, 2H), 7.70−7.80 (m, 2H), 7.55−7.65 (m, 1H), 7.28−7.32 (m, 1H), 4.43 (s, 2H), 3.55 (t, <i>J</i> = 6.0 Hz, 2H), 2.68 (t, <i>J</i> = 5.6 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 367 (M + H)<sup>+</sup>. HPLC purity: 96%.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-((2-(Pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methyl)benzonitrile (<b>11g</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine (50 mg, 0.248 mmol) in dry DMF (5 mL) was added K<sub>2</sub>CO<sub>3</sub> (69 mg, 0.496 mmol) and 3-(bromomethyl)benzonitrile (49 mg, 0.248 mmol) . The mixture was stirred at room temperature overnight and then concentrated. The residue was purified by preparative HPLC to afford 3-((2-(pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methyl) benzonitrile (10 mg, 13%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.65 (d, <i>J</i> = 4.0 Hz, 1H), 8.40 (d, <i>J</i> = 8.0 Hz, 1H), 7.83−7.79 (m, 1H), 7.74−7.67 (m, 3H), 7.54−7.51 (m, 1H), 7.39−7.37 (m, 1H), 4.25 (s, 2H), 4.20 (s, 2H), 3.42 (t, <i>J</i> = 6.0 Hz, 2H), 2.98 (t, <i>J</i> = 6.0 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 339 (M + H)<sup>+</sup>. HPLC purity: 97%.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (±)-3-(2-(Piperidin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>11h</b>)</h3><div class="NLM_p last">The title compound was prepared in a manner similar to <b>11i</b> starting from 1-(benzyloxycarbonyl)piperidine-2-carboxylic acid and (<i>±</i>)-<i>trans</i>-4-amino-3-hydroxy-piperidine-1-carboxylic acid benzyl ester. The title compound was isolated as a white solid (15 mg, 21%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.29−7.34 (m, 1H), 7.06−7.12 (m, 3H), 4.27 (s, 2H), 3.86−3.90 (m, 1H), 3.62 (t, <i>J</i> = 5.6 Hz, 2H), 3.10−3.14 (m, 1H), 2.70−2.76 (m, 3H), 1.99−2.04 (m, 2H), 1.85−1.87 (m, 1H), 1.61−1.71 (m, 2H), 1.47−1.53 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 311 (M + H)<sup>+</sup>. HPLC purity: 95%.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 3-(2-(Pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>11i</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine (100 mg, 0.5 mmol) in <i>t</i>-BuOH (2 mL) was added 3-chlorobenzonitrile (102 mg, 0.6 mmol), <i>t</i>-BuONa (100 mg, 1 mmol), Pd<sub>2</sub>dba<sub>3</sub> (5 mg, cat.), and BINAP (5 mg, cat.). The mixture was heated to 110 °C via microwave and stirred for 1 h. The reaction mixture was cooled, dissolved in MeOH, and filtered. The filtrate was concentrated, and the residue was purified by preparative HPLC to afford 3-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[4,5-<i>c</i>]pyridine-5(4<i>H</i>)-yl)benzonitrile (10 mg, 7%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.71 (s, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 7.85 (t, <i>J</i> = 6.8 Hz, 1H), 7.40 (t, <i>J</i> = 6.8 Hz, 1H), 7.30 (t, <i>J</i> = 8.0 Hz, 1H), 7.07 (m, 3H), 4.40 (s, 2H), 3.68 (t, <i>J</i> = 5.6 Hz, 2H), 2.82 (t, <i>J</i> = 5.6 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 303 (M + H)<sup>+</sup>. HPLC purity: 99%.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 3-(2-(Pyridin-3-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>11j</b>)</h3><div class="NLM_p last">The title compound was prepared via the procedure used for <b>11k</b>, substituting nicotinic acid for picolinic acid and substituting 3-bromobenzonitrile for 3-bromo-5-fluorobenzonitrile. Preparative HPLC afforded 3-(2-pyridin-3-yl-6,7-dihydro-4<i>H</i>-oxazolo[5,4-<i>c</i>]pyridin-5-yl)-benzonitrile as a light-yellow solid (11 mg, 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.33 (d, <i>J</i> = 1.2 Hz, 1H), 8.75 (dd, <i>J</i><sub>1</sub> = 4.0 Hz, <i>J</i><sub>2</sub> = 1.2 Hz, 1H), 8.59 (dd, <i>J</i><sub>1</sub> = 9.6 Hz, <i>J</i><sub>2</sub> = 1.6 Hz, 1H), 7.69 (dd, <i>J</i><sub>1</sub> = 8.4 Hz, <i>J</i><sub>2</sub> = 5.2 Hz, 1H), 7.38−7.34 (m, 1H), 7.17−7.12 (m, 3H), 4.43 (s, 2H), 3.71 (t, <i>J</i> = 4.8 Hz, 2H), 2.86 (t, <i>J</i> = 4.8 Hz, 2H). MS (ESI): <i>m</i>/<i>e</i> = 303 [M + 1].</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 3-Fluoro-5-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (<b>11k</b>)</h3><div class="NLM_p last">To a solution of 2-(4-chlorophenyl)-4,5,6,7-tetrahydrooxazolo[5,4-<i>c</i>]pyridine (20 mg, 0.1 mmol) in toluene was added 3-bromo-5-fluorobenzonitrile (30 mg, 0.15 mmol), Cs<sub>2</sub>CO<sub>3</sub> (65 mg, 0.2 mmol), Pd(OAc)<sub>2</sub> (1 mg, cat.), and Xantphos (2 mg, cat.). The mixture was heated to 100 °C and stirred overnight. The mixture was cooled, dissolved in MeOH, and filtered. The filtrate was concentrated, and the residue was purified by preparative TLC to afford 3-fluoro-5-(2-(pyridin-2-yl)-6,7-dihydrooxazolo[5,4-<i>c</i>]pyridin-5(4<i>H</i>)-yl)benzonitrile (10 mg, 31%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.68 (d, <i>J</i> = 8.0 Hz, 1H), 8.05 (d, <i>J</i> = 7.6 Hz, 1H), 7.77 (t, <i>J</i> = 7.6 Hz, 1H), 7.32 (t, <i>J</i> = 6.0 Hz, 1H), 6.90 (s, 1H), 6.75 (m, 2H), 4.40 (s, 2H), 3.68 (t, <i>J</i> = 5.6 Hz, 2H), 2.80 (t, <i>J</i> = 7.2 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 321 (M + H)<sup>+</sup>. HPLC purity: 96%.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Benzyl (3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-yl)methylcarbamate (<b>16</b>)</h3><div class="NLM_p last">Benzyl 2-hydrazinyl-2-oxoethylcarbamate (16.4 g, 73.6 mmol) and ethyl picolinimidate <b>15</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (13.3 g, 88.3 mmol) were combined in EtOH (150 mL). The mixture was heated at reflux overnight. Acetic acid (60 mL) was added, and the mixture was stirred at reflux for 2 h. The mixture was concentrated to dryness. Trituration using ether afforded the product as a brown solid (21 g, 92%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>): δ 8.64 (s, 1H), 8.08 (m, 1H), 7.92 (m, 1H), 7.45 (s, 1H), 7.16−7.42 (m, 5H), 5.12 (s, 2H), 4.48 (s, 2H). LC/MS: <i>m</i>/<i>e</i> = 310 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Ethyl 2-(5-((benzyloxycarbonylamino)methyl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)acetate (<b>17</b>)</h3><div class="NLM_p last">Benzyl (3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-5-yl)methylcarbamate (10.0 g, 32.3 mmol) was dissolved in THF (100 mL) and cooled to 0 °C. Potassium <i>t</i>-butoxide (3.63 g, 32.3 mmol) was added. Ethyl bromoacetate (5.4 g, 32.3 mmol) was dissolved in DMF and added dropwise, and the reaction was stirred at room temperature for 4 h. The DMF was removed in vacuo and the residue dissolved in EtOAc. The organic layer was washed with saturated NaHCO<sub>3</sub> solution and brine, then dried over Na<sub>2</sub>SO<sub>4</sub>. Purification by reverse phase chromatography (Gilson GX-281 (NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile)) gave a yellow oil (5.21 g, 41%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.70 (d, <i>J</i> = 5.0 Hz, 1H), 8.08 (d, <i>J</i> = 8.0 Hz, 1H), 7.77 (t, <i>J</i> = 8.0 Hz, 1H), 7.28−7.38 (m, 5H), 5.59 (s, 1H), 5.2 (s, 2H), 5.1 (s, 2H), 4.55 (d, <i>J</i> = 6.0 Hz, 2H), 4.21 (q, <i>J</i> = 12.0 Hz, 2H), 1.22−1.32 (t, <i>J</i> = 12.0 Hz, 3H). LC/MS: <i>m</i>/<i>e</i> = 396 (M + H)<sup>+</sup>. HPLC purity: 93%.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(Pyridin-2-yl)-7,8-dihydro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-6(5<i>H</i>)-one (<b>18</b>)</h3><div class="NLM_p last">Ethyl 2-(5-((benzyloxycarbonylamino)methyl)-3-(pyridin-2-yl)-1<i>H</i>-1,2,4-triazol-1-yl)acetate (4.94 g, 12.4 mmol) was dissolved in MeOH (50 mL). Palladium on carbon catalyst (10%, 300 mg, 6% w/w) was added, and the reaction was stirred under hydrogen atmosphere (1 atm) for 3 h. The catalyst was removed by filtration through Celite, washed several times with hot methanol, and the combined filtrates concentrated to give a white solid (2.03 g, 76%). <sup>1</sup>H NMR (400 MHz, MeOH-<i>d</i><sub>4</sub>): δ 8.63 (m, 1H), 8.12 (d, <i>J</i> = 10.0 Hz, 1H), 7.93 (m, 1H), 7.46 (m, 1H), 4.93 (s, 2H), 4.7 (s, 2H). LC/MS: <i>m</i>/<i>e</i> = 216 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 2-(Pyridin-2-yl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazine (<b>19</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-7,8-dihydro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-6(5<i>H</i>)-one (1.63 g, 7.57 mmol) in THF (40 mL) was added dropwise a solution of BH<sub>3</sub>/THF (30 mL, 1M, 30.0 mmol). The reaction was stirred at room temperature under N<sub>2</sub> for 15 min, then heated at reflux under N<sub>2</sub> for 4 h. The reaction was cooled in an ice bath. 4N HCl in dioxane (8 mL) and MeOH (8 mL) were added dropwise, and the reaction was heated to reflux for 2 h. The mixture was concentrated to dryness on the rotavap. MeOH was added to the crude and evaporated. This process of dilution and evaporation was repeated a total of 5 times. Brine (1 mL) was added, and the solution was extracted with DCM (2 × 5 mL). The pH of the aqueous layer was adjusted to 14 using 6N NaOH and extracted with DCM (4 × 5 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated to give a yellow solid (400 mg, 26%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.71 (d, <i>J</i> = 5.0 Hz, 1H), 8.08 (d, <i>J</i> = 8.0 Hz, 1H), 7.77 (t, <i>J</i> = 8.0 Hz 1H), 7.30 (m, 1H), 4.25 (m, 4H), 3.38 (t, <i>J</i> = 5.0 Hz, 2H). LC/MS: <i>m</i>/<i>e</i> = 202 (M + H)<sup>+</sup>. HPLC purity: 98%.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-Fluoro-5-(2-(pyridin-2-yl)-5,6-dihydro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazin-7(8<i>H</i>)-yl)benzonitrile (<b>20</b>)</h3><div class="NLM_p last">2-(Pyridin-2-yl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-<i>a</i>]pyrazine (112 mg, 0.56 mmol), tris(dibenzylideneacetone)dipalladium(0) (10 mg, 0.011 mmol), Xantphos (19 mg, 0.033 mmol), Cs<sub>2</sub>CO<sub>3</sub> (362 mg, 1.11 mmol), and 3-bromo-5-fluorobenzonitrile (245 mg, 1.22 mmol) were combined in xylene (4 mL). The mixture was stirred under microwaves at 150 °C for 30 min. The solvent was evaporated, and the crude material was purified by silica gel chromatography (9/1 DCM/MeOH). The fractions containing the desired product were collected and combined and then purified by reverse phase purification (Gilson GX-281 (NH<sub>4</sub>HCO<sub>3</sub>/acetonitrile)) to give the desired product as a colorless oil (1.1 mg, 0.6%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.72 (s, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.80 (t, <i>J</i> = 8.0 Hz, 1H), 7.33 (m, 1H), 7.10 (s, 1H), 6.90 (m, 2H), 4.65 (s, 2H), 4.45 (s, 2H), 3.90 (s, 2H). LC/MS: <i>m</i>/<i>e</i> = 321 (M + H)<sup>+</sup>. HPLC purity: 100%.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3-Bromo-1-tosylpiperidin-4-one (<b>22</b>)</h3><div class="NLM_p last">To a solution of 1-(4′-methylphenylsulfonyl)piperidine-4-one (34.8 g, 137.5 mmol) in DCM (860 mL) at −5 °C was added a solution of bromine (21.73 g, 137.5 mmol) in DCM (135 mL) dropwise over 2 h. The temperature of the reaction was maintained between −4 and −2 °C. The resulting solution was allowed to warm to room temperature until the color of bromine disappeared. Saturated NaHCO<sub>3</sub> was added and stirring continued for 30 min. The organic layer was separated, and the aqueous layer was extracted with DCM (500 mL). The combined organic layer was dried over sodium sulfate, filtered, and evaporated to dryness to afford the title compound as a white solid (44.6 g, 98%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 4.55 (dd, <i>J</i><sub>1</sub> = 5.2 Hz, <i>J</i><sub>2</sub> = 8.4 Hz, 1H), 3.98 (ddd, <i>J</i><sub>1</sub> = 1.6 Hz, <i>J</i><sub>2</sub> = 5.2 Hz, <i>J</i><sub>3</sub> = 13.2 Hz, 1H), 3.62−3.66 (m, 1H), 3.22−3.38 (m, 2H), 2.96 (dt, <i>J</i><sub>1</sub> = 5.2 Hz, <i>J</i><sub>2</sub> = 14.4 Hz, 1H), 2.62−2.70 (m, 1H), 2.45 (s, 3H). LC/MS: <i>m</i>/<i>e</i> = 332 (M + H)<sup>+</sup>. HPLC purity: 97%.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl 6-Bromo-5-oxo-1-tosylazepane-4-carboxylate (<b>23a</b>)</h3><div class="NLM_p last">To a solution of 3-bromo-1-tosylpiperidin-4-one (39.3 g, 118.7 mmol) in anhydrous DCM (1.3 L) at −5 °C under argon was added a solution of BF<sub>3</sub>·Et<sub>2</sub>O (22 g, 1.25 equiv, 148.4 mmol) in DCM (180 mL) over 60 min. The reaction was stirred at −5 °C for 45 min, and a solution of ethyl diazoacetate (16.9 g, 148.4 mmol) in DCM (180 mL) was added over 90 min. The mixture was stirred at 0 °C for 1 h, and water was added slowly. The mixture was stirred at room temperature for 30 min. The organic layer was separated, dried over sodium sulfate, filtered, and concentrated in vacuo to give a pale-yellow solid which was recrystallized from ethyl acetate to give ethyl 6-bromo-5-oxo-1-tosylazepane-4-carboxylate <b>23a</b> as a white solid (35.69 g, 72%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.66 (d, <i>J</i> = 8.4 Hz, 2H), 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 4.45 (dd, <i>J</i><sub>1</sub> = 6.8 Hz, <i>J</i><sub>2</sub> = 11.2 Hz, 1H), 4.19−4.3 (m, 3H), 3.94 (dd, <i>J</i><sub>1</sub> = 2.8 Hz, <i>J</i><sub>2</sub> = 9.2 Hz, 1H), 4.03 (dt, <i>J</i><sub>1</sub> = 2.8 Hz, <i>J</i><sub>2</sub> = 12.0 Hz, 1H), 3.07 (dd, <i>J</i><sub>1</sub> = 15.2 Hz, <i>J</i><sub>2</sub> = 10.8 Hz, 1H), 2.80 (ddd, <i>J</i><sub>1</sub> = 14 Hz, <i>J</i><sub>2</sub> = 12 Hz, <i>J</i><sub>3</sub> = 2.8 Hz, 1H), 2.44 (s, 3H), 2.2 (m, 1H), 2.0−2.1 (m, 1H), 1.26 (t, <i>J</i> = 6.8 Hz, 3H). LC/MS: <i>m</i>/<i>e</i> = 418 (M + H)<sup>+</sup>. HPLC purity: 93%.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 3-Bromo-1-tosylazepan-4-one (<b>23b</b>)</h3><div class="NLM_p last">A suspension of ethyl 6-bromo-5-oxo-1-tosylazepane-4-carboxylate (35.7 g, 85.6 mmol) in dioxane (540 mL) was heated to 80 °C. 3N HCl (290 mL) was added to the mixture over 30 min. The resulting solution was heated to 100 °C for 6 h. The dioxane was removed in vacuo, and the aqueous layer was extracted with DCM. The combined organic layer was dried, filtered, and evaporated to give the crude product, which was recrystallized from diisopropyl ether to give 3-bromo-1-tosylazepan-4-one 23b as a white solid (26.5 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.67 (d, <i>J</i> = 8.8 Hz, 2H), 7.34 (d, <i>J</i> = 8.0 Hz, 2H), 4.37 (dd, <i>J</i><sub>1</sub> = 10.8 Hz, <i>J</i><sub>2</sub> = 6.4 Hz, 1H), 4.24 (dd, <i>J</i><sub>1</sub> = 6.4 Hz, <i>J</i><sub>2</sub> = 14.4 Hz, 1H), 3.90 (dt, <i>J</i><sub>1</sub> = 4.4 Hz, <i>J</i><sub>2</sub> = 13.6 Hz, 1H), 3.05 (m, 1H), 2.75−2.92 (m, 2H), 2.55−2.59 (m, 1H), 2.44 (s, 3H), 1.8−1.97 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 346 (M + H)<sup>+</sup>. HPLC purity: 90%.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 3-Azido-1-tosylazepan-4-one (<b>24</b>)</h3><div class="NLM_p last">To a solution of 3-bromo-1-tosylazepan-4-one (26.5 g, 76.8 mmol) in dry DMF (580 mL) was added acetic acid (9.22 g, 153.6 mmol) and sodium azide (9.98 g, 153.6 mmol) under nitrogen. The resulting solution was stirred at room temperature for 16 h. The mixture was poured onto ice−water, and the aqueous solution was extracted with ethyl acetate. The combined organic layer was washed with brine, dried, filtered, and evaporated. The crude product was recrystallized from <i>tert</i>-butyl methyl ether to give 3-azido-1-tosylazepan-4-one <b>24</b> as a pale-yellow solid (19 g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 7.68 (d, <i>J</i> = 6.8 Hz, 2H), 7.34 (d, <i>J</i> = 7.6 Hz, 2H), 4.20 (dd, <i>J</i><sub>1</sub> = 5.2 Hz, <i>J</i><sub>2</sub> = 8.8 Hz, 1H), 3.77 (dd, <i>J</i><sub>1</sub> = 14.8 Hz, <i>J</i><sub>2</sub> = 5.2 Hz, 1H), 3.68 (m, 1H), 3.01−3.07 (m, 2H), 2.59−2.65 (m, 2H), 2.44 (s, 3H), 1.83−2.0 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 309 (M + H)<sup>+</sup>. HPLC purity: 78%.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-Amino-1-tosylazepan-4-ol (<b>25</b>)</h3><div class="NLM_p last">To a suspension of lithium aluminum hydride (760 mg, 20 mmol) in THF (15 mL) was added 3-azido-1-tosylazepan-4-one (3.08 g 10 mmol) in THF (35 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 30 min and was quenched with saturated Na<sub>2</sub>SO<sub>4</sub> aqueous solution. The mixture was extracted with EtOAc and saturated sodium bicarbonate. The organic layer was dried over sodium sulfate, filtered, and evaporated to obtain the crude product. The residue was purified by column chromatography (eluting solvent: DCM/methanol = 20/1) to give 3-amino-1-tosylazepan-4-ol <b>25</b> (1.45 g, 52%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.66 (dd, <i>J</i><sub>1</sub> = 2.0 Hz, <i>J</i><sub>2</sub> = 8.4 Hz, 2H), 7.31 (dd, <i>J</i><sub>1</sub> = 8.0 Hz, <i>J</i><sub>2</sub> = 2.0 Hz, 2H), 3.62−3.64 (m, 0.5H), 3.48 (dd, <i>J</i><sub>1</sub> = 3.6 Hz, <i>J</i><sub>2</sub> = 14.4 Hz, 0.5H), 3.03−3.33 (m, 4H), 2.77−2.90 (m, 1H), 2.43 (s, 3H), 1.91−1.98 (m, 2H), 1.66−1.78 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 285 (M + H)<sup>+</sup>. HPLC purity: 85%.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(4-Hydroxy-1-tosylazepan-3-yl)picolinamide (<b>26</b>)</h3><div class="NLM_p last">To a solution of picolinic acid (615 mg, 5 mmol) in DCM (15 mL) was added EDCI (1.43 g, 7.5 mmol), HOBt (1.01 g, 7.5 mmol), and triethylamine (758 mg, 7.5 mmol). The solution was stirred at room temperature for 10 min. 3-Amino-1-tosylazepan-4-ol (1.42 g, 5 mmol) in DCM (5 mL) was added to the reaction, and the resulting mixture was stirred at room temperature overnight. The reaction was diluted with DCM and washed with saturated sodium bicarbonate solution. The organic layer was dried over sodium sulfate, filtered, and evaporated. The crude product was purified by column chromatography to obtain <i>N</i>-(4-hydroxy-1-tosylazepan-3-yl)picolinamide <b>26</b> (1.55 g, 80%) (eluting solvent:dichloromethane/methanol = 50/1). LC/MS: <i>m</i>/<i>e</i> = 390 (M + H)<sup>+</sup>. HPLC purity: 92%.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(4-Oxo-1-tosylazepan-3-yl)picolinamide (<b>27</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-(4-hydroxy-1-tosylazepan-3-yl)picolinamide (1.16 g, 2.98 mmol) in DCM (20 mL) was added Dess−Martin periodinane (3.82 g, 8.9 mmol) in one portion. The reaction was stirred at room temperature for 3 h and then diluted with DCM. The mixture was cooled to 0 °C, and ice-cold 0.5N sodium hydroxide solution was added. The biphasic mixture was stirred at 0 °C for 1 h. The organic layer was separated, dried over sodium sulfate, and concentrated in vacuo to obtain <i>N</i>-(4-oxo-1-tosylazepan-3-yl)picolinamide <b>27</b> (1.06 g, 92%). LC/MS: <i>m</i>/<i>e</i> = 388 (M + H)<sup>+</sup>. HPLC purity: 93%.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 2-(Pyridin-2-yl)-5-tosyl-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine (<b>28a</b>)</h3><div class="NLM_p last">A mixture of <i>N</i>-(4-oxo-1-tosylazepan-3-yl)picolinamide (10.0 g, 25.8 mmol) and Burgess’ reagent (21.49 g, 90.3 mmol) in dry THF (40 mL) was heated to 150 °C by microwave and stirred for 45 min. The reaction mixture was diluted with water and extracted with DCM. The organic layer was dried over sodium sulfate and evaporated to dryness. The crude product was recrystallized from methanol to give 2-(pyridin-2-yl)-5-tosyl-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine <b>28a</b> (7.4 g, 78%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 8.70 (d, <i>J</i> = 4.4 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 1H), 7.81 (dt, <i>J</i><sub>1</sub> = 2.0 Hz, <i>J</i><sub>2</sub> = 8.0 Hz, 1H), 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.33−7.37 (m, 1H), 7.28 (d, <i>J</i> = 8.0 Hz, 2H), 4.43 (s, 2H), 3.51−3.54 (m, 2H), 2.92 (t, <i>J</i> = 6.4 Hz, 2H), 2.39 (s, 3H), 2.03−2.49 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 370 (M + H)<sup>+</sup>. HPLC purity: 93%.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-(Pyridin-2-yl)-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine (<b>28b</b>)</h3><div class="NLM_p last">A solution of 2-(pyridin-2-yl)-5-tosyl-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine (7.4 g, 20 mmol) in 48% aqueous hydrobromide solution (100 mL) was heated to 100 °C and stirred for 3 h. The mixture was cooled to room temperature and extracted with <i>tert</i>-butyl methyl ether. The aqueous layer was adjusted to pH 13 with sodium hydroxide solution and extracted with dichloromethane. The combined organic layer was dried over sodium sulfate, filtered, and evaporated to obtain 2-(pyridin-2-yl)-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine <b>28b</b> (3.4 g, 74%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD), δ 8.62−8.64 (m, 1H), 8.07 (td, <i>J</i><sub>1</sub> = 1.2 Hz, <i>J</i><sub>2</sub> = 8.4 Hz, 1H), 7.96 (dt, <i>J</i><sub>1</sub> = 2.0 Hz, <i>J</i><sub>2</sub> = 7.6 Hz, 1H), 7.47−7.51 (m, 1H), 3.90 (s, 2H), 3.08−3.10 (m, 2H), 3.00 (t, <i>J</i> = 6.0 Hz, 2H), 1.93−1.98 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 216 (M + H)<sup>+</sup>. HPLC purity: 96%.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 3-(2-(Pyridin-2-yl)-7,8-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepin-5(6<i>H</i>)-yl)benzonitrile (<b>29a</b>)</h3><div class="NLM_p last">To a solution of 2-(pyridin-2-yl)-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine (20 mg, 0.09 mmol) in toluene (2 mL) was added 3-bromobenzonitrile (25 mg, 0.14 mmol), Cs<sub>2</sub>CO<sub>3</sub> (61 mg, 0.18 mmol), Pd(OAc)<sub>2</sub> (1 mg, cat.), and Xantphos (2 mg, cat.). The mixture was heated to 100 °C and stirred overnight. The reaction was cooled, diluted with MeOH, and filtered. The filtrate was concentrated and the residue was purified by prep-TLC to afford the title compound (5 mg, 17%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.65 (d, <i>J</i> = 4.4 Hz, 1H), 8.00 (d, <i>J</i> = 8.0 Hz, 1H), 7.75 (t, <i>J</i> = 6.0 Hz, 1H), 7.27 (t, <i>J</i> = 4.8 Hz, 1H), 7.15−7.20 (m, 1H), 6.95−7.00 (m, 2H), 6.80 (d, <i>J</i> = 7.2 Hz, 1H), 4.49 (s, 2H), 3.78 (t, <i>J</i> = 4.8 Hz, 2H), 2.94 (t, <i>J</i> = 6.0 Hz, 2H), 1.87−1.96 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 317 (M + H)<sup>+</sup>. HPLC purity: 94%</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 3-Fluoro-5-(2-(pyridin-2-yl)-7,8-dihydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepin-5(6<i>H</i>)-yl)benzonitrile (<b>29b</b>)</h3><div class="NLM_p last">To a microwave tube flushed with argon was added potassium <i>t</i>-butoxide (1.35 g, 12 mmol), tris(dibenzylideneacetone)dipalladium(0) [Pd<sub>2</sub>(dba)<sub>3</sub>] (275 mg, 0.3 mmol), Xantphos (347 mg, 0.6 m mol), 2-(pyridin-2-yl)-5,6,7,8-tetrahydro-4<i>H</i>-oxazolo[4,5-<i>c</i>]azepine (1.3 g, 6 mmol), 3-bromo-5-fluorobenzonitrile (1.8 g, 9 mmol), and dry toluene (30 mL). The reaction mixture was heated to 100 °C via microwave and stirred for 70 min. The reaction mixture was diluted with ethyl acetate and washed with brine. The combined organic layer was dried over sodium sulfate, filtered, and evaporated to dryness. The crude product was purified by column chromatography on silica gel (PE/EA = 5/1−1/1) to give the title compound as a yellow solid (440 mg, 22%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.70 (d, <i>J</i> = 4.8 Hz, 1H), 8.06 (td, <i>J</i><sub>1</sub> = 1.2 Hz, <i>J</i><sub>2</sub> = 8.0 Hz, 1H), 7.82 (dt, <i>J</i><sub>1</sub> = 1.6 Hz, <i>J</i><sub>2</sub> = 8.0 Hz, 1H), 7.33−7.37 (m, 1H), 6.83−6.84 (m, 1H), 6.72 (td, <i>J</i><sub>1</sub> = 2.4 Hz, <i>J</i><sub>2</sub> = 12 Hz, 1H), 6.64−6.67 (m, 1H), 4.53 (s, 2H), 3.80−3.83 (m, 2H), 3.02 (t, 2H, <i>J</i> = 6.0 Hz), 1.99−2.02 (m, 2H). LC/MS: <i>m</i>/<i>e</i> = 335 (M + H)<sup>+</sup>. HPLC purity: 98%.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> mGluR5 Functional Assay</h3><div class="NLM_p last">The functional assay utilized an aequorin cell line expressing human recombinant mGluR5 receptor, an inducible cell line that expresses the human receptor under the control of a promoter induced by doxycycline. mGluR5 cells in midlog phase, grown 18 h prior to the test in antibiotic-free media supplemented with doxycycline (600 ng/mL), were detached by gentle flushing with PBS−EDTA (5 mM EDTA). The cells were recovered by centrifugation and resuspended in assay buffer (HBSS, 2.1 mM CaCl<sub>2</sub>, 3 μg/mL glutamate−pyruvate transaminase, 4 mM MEM sodium pyruvate, 0.1% BSA protease-free). Cells were incubated at room temperature for at least 4 h with coelenterazine-h (Molecular Probes). The cell suspension was incubated with the test compound in a volume of 60 μL for at least 3 min, followed by the addition of a 30 μL of glutamate solution to give a final concentration sufficient for a response 80% of the maximal response given by saturating glutamate (EC<sub>80</sub>). The resulting emission of light was recorded using a Hamamatsu Functional Drug Screening System 6000 (FDSS 6000). To standardize the emission of recorded light (determination of the “100% signal”) across plates and across different experiments, some wells contained 100 μM digitonin or a saturating concentration (20 μM) of adenosine triphosphate. Percentages of inhibition were calculated on the basis of the activation induced by the agonist glutamate at its EC<sub>80</sub>. Dose−response data were analyzed with XLFit (IDBS) software using nonlinear regression applied to a sigmoidal dose-response model.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> mGluR5 Rat Binding Assay</h3><div class="NLM_p last">The radioligand binding assay was a competition assay performed in duplicate. To a Minisorb tube was added buffer (15 mM tris(hydroxymethyl)aminomethane hydrochoride, 120 mM sodium chloride, 100 mM potassium chloride, 25 mM magnesium chloride, 25 mM calcium chloride, pH 7.4), rat cortical membrane extracts (between 50 and 200 μg protein/well), [<sup>3</sup>H]-MPEP (American Radiolabeled Chemicals, Inc.) (0.6 nM), and test compound at increasing concentrations. Nonspecific binding was determined by coincubation with a 200-fold excess of <b>1</b> (Tocris). The samples were incubated in a final volume of 0.1 mL for 120 min at 4 °C and then filtered over Whatman GF-C filters that had been presoaked in washing buffer containing 0.1% polyethyleneimine for 2 h at room temperature. The filters were washed three times with 3 mL of cold washing buffer (50 mM tris(hydroxymethyl)aminomethane hydrochoride, pH 7.4). Microscint 20 fluid (2 mL) (Packard) was added to each tube, and the tubes were counted with a Tricarb counter for 1 min/tube.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> mGluR5 Rat Receptor Occupancy Assay</h3><div class="NLM_p">All animal experimental procedures were carried out in accordance with the governmental guidelines and approved by the Institutional Animal Care and Use Committee (IACUC). In vivo occupancy studies for the negative allosteric modulator site of the mGluR5 receptor were performed using <sup>3</sup>H-mPEPy (Moravek Biochemicals; specific activity ∼58−61 Ci/mmol). Male Sprague−Dawley rats (Harlan, 200−250 g; <i>n</i> = 4 per group) were injected intraperitoneally or orally (po) with either vehicle (45% hydroxypropyl-β-cyclodextrin, HPβCD) or test compounds. Sixty min after drug administration (or otherwise stated in the case of the time-course experiment), <sup>3</sup>H-mPEPy (120uCi/kg; 1 mL/kg in saline) was administered as a bolus intravenous injection via the tail vein. Two minutes after <sup>3</sup>H-mPEPy administration, rats were euthanized by rapid decapitation and trunk blood and brains harvested. Brains were dissected and frozen immediately in isopentane cooled in dry ice and stored at −80 °C until required for tissue sectioning. Blood samples were centrifuged (20 min, 3000<i>g</i>, 6 °C), and the resulting plasma samples were stored at −80 °C until required for drug level analysis. For tissue sectioning and image processing, brains were removed from storage (−80 °C) and allowed to thaw to −20 °C for tissue sectioning on a Leica CM1900 cryostat. Coronal sections (12 mm) of striatum (the region of interest) and cerebellum (reference region) were cut and thaw-mounted onto glass microscope slides. Images of brain sections from vehicle and drug-treated animals were generated by placing the slide-mounted sections in a Biospace β-imager (Biospace Inc., France) for 12 h. Striatal and cerebellar images were quantitated and expressed as units radioactivity/mm<sup>2</sup> using the b-vision plus software supplied by Biospace. Signal:noise (striatum:cerebellum) ratio (<i>S</i>:<i>N</i>) was calculated and the receptor occupancy (%RO) was determined for each subject using the following formula:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/jm-2010-00736h_m001.gif" alt="" /></img></span></div><div class="NLM_p">Data are expressed as mean %RO ± standard error of the mean. Dose−occupancy curves for <b>29b</b> at the mGluR5 NAM site were generated using Prism ver5.0.</div><div class="NLM_p last">To determine plasma and brain concentrations, sample preparation began with the addition of rat brain (200 mg) to a 15 mL plastic test tube and dilution to 40 mg/mL with 95:5 water:acetonitrile containing 0.1% formic acid. The mixture was then homogenized using an ultrasonic homogenizer for 1 min. A 60 μL aliquot of plasma or homogenized rat brain was placed into a 96 deep well plate, and 200 μL of acetonitrile was added to precipitate the proteins. Samples were vortexed for 1 min and centrifuged at 4500 rpm for 15 min at 4 °C. Then 200 μL aliquots of supernatant was transferred to a deep-well 96 plate, and evaporated to dryness. The samples were then reconstituted in 150 μL 90:10 5 water:acetonitrile with 0.1% formic acid and centrifuged at 4500 rpm for 15 min at 4 °C. A 45 μL aliquot from the supernatant was injected into the LC/MS/MS instrument.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Rat Pharmacokinetics</h3><div class="NLM_p last">The pharmacokinetics of <b>29b</b> was determined in male Sprague−Dawley rats following an intravenous dose of 2 mg/kg and oral doses of 2 mg/kg and 10 mg/kg (<i>N</i> = 3 animals/cohort). The test article was dissolved in 40% hydroxypropyl-βCD:50 mM potassium phosphate pH 6.0 50:50 to yield a nominal concentration of 0.5 mg/mL (pH = 6−7). The formulation was filtered through a 0.22 μm filter to achieve a clear solution prior to iv dosing (4 mL/kg) and oral gavage (4 mL/kg and 20 mL/kg for the 2 mg/kg and 10 mg/kg doses, respectively). Blood samples (approximately 300 μL) were collected via jugular cannula predose and at 5 min, 0.25, 0.50, 1, 2, 4, 6, 8, and 24 h postdose. Following blood collection at each time point, approximately 300 μL of sterile 0.9% sodium chloride was injected through the cannula to replace the volume of blood collection. Blood samples were placed into tubes containing sodium K<sub>2</sub>-EDTA and centrifuged under refrigerated conditions at 8000 rpm for 6 min at 4 °C to separate plasma from sample. Following centrifugation, the supernatant was transferred to clean tubes and stored frozen at −80 °C pending bioanalysis. For bioanalysis, plasma samples (0.05 mL) were transferred to tubes, and 250 μL of a methanol solution containing internal standard (200 ng/mL) was added to each sample. After vortexing for 1 min and centrifuging for 5 min at 15000 rpm, 100 μL aliquots of supernatant were transferred to glass autosampler vials for LC/MS/MS analysis. The lower limit of quantitation (LLOQ) was 2.5 ng/mL. All pharmacokinetic parameters were calculated using a noncompartmental model in the WinNonlin program.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Monkey Pharmacokinetics</h3><div class="NLM_p last">The pharmacokinetics of <b>29b</b> was determined in male Rhesus monkeys following an intravenous dose of 1 mg/kg and an oral dose of 1 mg/kg (<i>N</i> = 3 animals/cohort). The test article was dissolved in 40% hydroxypropyl-βCD:50 mM potassium phosphate pH 6.0 50:50 to yield a nominal concentration of 0.5 mg/mL (pH = 6). The formulation was filtered through a 0.22 μm filter to achieve a clear solution prior to iv dosing and oral gavage (2 mL/kg). Blood samples (approximately 1 mL) were collected via femoral vein predose and at 5 min, 0.25, 0.50, 1, 2, 4, 6, 8, and 24 h postdose. Blood samples were placed into tubes containing K<sub>3</sub>EDTA and centrifuged at 3500 rpm for 10 min at 4 °C to separate plasma from sample. Following centrifugation, the supernatant was transferred to clean tubes and stored frozen at −80 °C pending bioanalysis. For bioanalysis, plasma samples (50 μL) were transferred to tubes and 500 μL of internal standard working solution (10 ng/mL) was added to each sample. After vortexing for 1 min and centrifuging for 5 min at 15000 rpm, 100 μL aliquots of supernatant were transferred to glass autosampler vials for LC/MS/MS analysis. The lower limit of quantitation (LLOQ) was 2.5 ng/mL. All pharmacokinetic parameters were calculated using a noncompartmental model in the WinNonlin program.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60"><a href="/doi/suppl/10.1021/jm100736h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthetic schemes for the preparation of <b>11c</b>, <b>11d</b>, <b>11h</b>, <b>11k</b>, <b>12b</b>, <b>13</b>, <b>14</b>, and <b>21</b>. Results from receptor panel screening (Cerep) for <b>5k</b> and <b>29b</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100736h/suppl_file/jm100736h_si_001.pdf">jm100736h_si_001.pdf (247.53 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100736h" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas F. Burdi</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#67030812000b061449051215030e2714021715060408154904080a"><span class="__cf_email__" data-cfemail="a4c0cbd1c3c8c5d78ac6d1d6c0cde4d7c1d4d6c5c7cbd68ac7cbc9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel Hunt</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lei Fan</span> - <span class="hlFld-Affiliation affiliation">Shanghai ChemPartner, Building no. 6, 998 Haki Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Hu</span> - <span class="hlFld-Affiliation affiliation">Shanghai ChemPartner, Building no. 6, 998 Haki Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Wang</span> - <span class="hlFld-Affiliation affiliation">Shanghai ChemPartner, Building no. 6, 998 Haki Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zihong Guo</span> - <span class="hlFld-Affiliation affiliation">Shanghai ChemPartner, Building no. 6, 998 Haki Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiqiang Huang</span> - <span class="hlFld-Affiliation affiliation">Shanghai ChemPartner, Building no. 6, 998 Haki Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chengde Wu</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, Peoples Republic of China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Larry Hardy</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Detheux</span> - <span class="hlFld-Affiliation affiliation">EuroScreen SA, Rue Adrienne Bolland 47, B6041 Gosselies, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Orsini</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria S. Quinton</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Lew</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kerry Spear</span> - <span class="hlFld-Affiliation affiliation">Discovery & Early Clinical Research, Sepracor Inc., 84 Waterford Drive, Marlborough, Massachusetts 01752</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Xiaoyue Su, Yinghua Yang, Yaobin Zhang, Gai Li, Dejin Li, Yunfei Zhu, Emilie Holder, and Florent Bernardin for their skillful technical assistance.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03422" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03422" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 22 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="note"><p class="first last">For reviews on metabotropic glutamate receptors, see:</p></div><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological Agents Acting at Subtypes of Metabotropic Glutamate Receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">–</span> <span class="NLM_lpage">1476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1016%2FS0028-3908%2899%2900092-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=10530808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVWnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1431-1476&author=D.+D.+Schoeppauthor=D.+E.+Janeauthor=J.+A.+Monn&title=Pharmacological+Agents+Acting+at+Subtypes+of+Metabotropic+Glutamate+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological agents acting at subtypes of metabotropic glutamate receptors</span></div><div class="casAuthors">Schoepp, D. D.; Jane, D. E.; Monn, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1431-1476</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with ∼270 refs.  Metabotropic (G-protein-coupled) glutamate (mGlu) receptors have now emerged as a recognized, but still relatively new area of excitatory amino acid research.  Current understanding of the roles and involvement of mGlu receptor subtypes in physiol./pathophysiol. functions of the central nervous system has been recently propelled by the emergence of various structurally novel, potent, and mGlu receptor selective pharmacol. agents.  This article reviews the evolution of pharmacol. agents that have been reported to target mGlu receptors, with a focus on the known receptor subtype selectivities of current agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1C80nlavsgrVg90H21EOLACvtfcHk0ljQLBC7llqTTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVWnsLc%253D&md5=08a832c7cab387bc096131bd2d916cab</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900092-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900092-1%26sid%3Dliteratum%253Aachs%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520Agents%2520Acting%2520at%2520Subtypes%2520of%2520Metabotropic%2520Glutamate%2520Receptors%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1431%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Niswender, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors: Physiology, Pharmacology and Disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=295-322&author=C.+H.+Niswenderauthor=P.+J.+Conn&title=Metabotropic+Glutamate+Receptors%3A+Physiology%2C+Pharmacology+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BH.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%253A%2520Physiology%252C%2520Pharmacology%2520and%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D295%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Chizh, B. A.</span><span> </span><span class="NLM_article-title">Novel Approaches to Targeting Glutamate Receptors for the Treatment of Chronic Pain: Review Article</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=169-176&author=B.+A.+Chizh&title=Novel+Approaches+to+Targeting+Glutamate+Receptors+for+the+Treatment+of+Chronic+Pain%3A+Review+Article"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChizh%26aufirst%3DB.%2BA.%26atitle%3DNovel%2520Approaches%2520to%2520Targeting%2520Glutamate%2520Receptors%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Pain%253A%2520Review%2520Article%26jtitle%3DAmino%2520Acids%26date%3D2002%26volume%3D23%26spage%3D169%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Keywood, C.; Wakefield, M. A</span><span> </span><span class="NLM_article-title">Single-Blind, Placebo-Controlled, Proof of Concept Study of the Effect of the mGluR5 Negative Allosteric Modulator, ADX10059, on 24 h Esophageal pH and Clinical Symptoms, in Patients with Gastroesophageal Reflux Disease (GERD)</span>. Presented at the <span class="NLM_conf-name">Sixth International Meeting on Metabotropic Glutamate Receptors</span>, <span class="NLM_conf-loc">Taormina, Sicily-Italy</span>, <span class="NLM_conf-date">September 14−19, 2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Keywood%2C+C.%3B+Wakefield%2C+M.+A+Single-Blind%2C+Placebo-Controlled%2C+Proof+of+Concept+Study+of+the+Effect+of+the+mGluR5+Negative+Allosteric+Modulator%2C+ADX10059%2C+on+24+h+Esophageal+pH+and+Clinical+Symptoms%2C+in+Patients+with+Gastroesophageal+Reflux+Disease+%28GERD%29.+Presented+at+the+Sixth+International+Meeting+on+Metabotropic+Glutamate+Receptors%2C+Taormina%2C+Sicily-Italy%2C+September+14%E2%88%9219%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKeywood%26aufirst%3DC.%26atitle%3DSingle-Blind%252C%2520Placebo-Controlled%252C%2520Proof%2520of%2520Concept%2520Study%2520of%2520the%2520Effect%2520of%2520the%2520mGluR5%2520Negative%2520Allosteric%2520Modulator%252C%2520ADX10059%252C%2520on%252024%2520h%2520Esophageal%2520pH%2520and%2520Clinical%2520Symptoms%252C%2520in%2520Patients%2520with%2520Gastroesophageal%2520Reflux%2520Disease%2520%2528GERD%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span>Addex Pharmaceuticals Home Page, <a href="http://www.addexpharma.com" class="extLink">http://www.addexpharma.com</a> (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Addex+Pharmaceuticals+Home+Page%2C+http%3A%2F%2Fwww.addexpharma.com+%28accessed+June+7%2C+2010%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAddex%2520Pharmaceuticals%2520Home%2520Page%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehrani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roppe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span> </span><span class="NLM_article-title">3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">204</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025570j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=204-206&author=N.+D.+P.+Cosfordauthor=L.+Tehraniauthor=J.+Roppeauthor=E.+Schweigerauthor=N.+D.+Smithauthor=J.+Andersonauthor=L.+Bristowauthor=J.+Brodkinauthor=X.+Jiangauthor=I.+McDonaldauthor=S.+Raoauthor=M.+Washburnauthor=M.+A.+Varney&title=3-%5B%282-Methyl-1%2C3-thiazol-4-yl%29ethynyl%5D-pyridine%3A+A+Potent+and+Highly+Selective+Metabotropic+Glutamate+Subtype+5+Receptor+Antagonist+with+Anxiolytic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm025570j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025570j%26sid%3Dliteratum%253Aachs%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DSchweiger%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMcDonald%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DM.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26atitle%3D3-%255B%25282-Methyl-1%252C3-thiazol-4-yl%2529ethynyl%255D-pyridine%253A%2520A%2520Potent%2520and%2520Highly%2520Selective%2520Metabotropic%2520Glutamate%2520Subtype%25205%2520Receptor%2520Antagonist%2520with%2520Anxiolytic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D204%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Berg, D.; Trenkwalder, C.; Eggert, K.; Csoti, I.; Storch, A.; Gasparini, F.; Hariry, S.; Johns, D. G.; Gomez-Mancilla, B. A.</span><span> </span><span class="NLM_article-title">Randomized, Controlled Trial Evaluating AFQ056 in Reducing Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease</span>. Presented at the <span class="NLM_conf-name">Movement Disorder Society Conference</span>, <span class="NLM_conf-loc">Paris, France</span>, <span class="NLM_conf-date">June 7−11, 2009</span>;  <span class="NLM_fpage">LB-05</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+D.%3B+Trenkwalder%2C+C.%3B+Eggert%2C+K.%3B+Csoti%2C+I.%3B+Storch%2C+A.%3B+Gasparini%2C+F.%3B+Hariry%2C+S.%3B+Johns%2C+D.+G.%3B+Gomez-Mancilla%2C+B.+A.+Randomized%2C+Controlled+Trial+Evaluating+AFQ056+in+Reducing+Levodopa-Induced+Dyskinesia+in+Patients+with+Parkinson%E2%80%99s+Disease.+Presented+at+the+Movement+Disorder+Society+Conference%2C+Paris%2C+France%2C+June+7%E2%88%9211%2C+2009%3B+LB-05."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DD.%26atitle%3DRandomized%252C%2520Controlled%2520Trial%2520Evaluating%2520AFQ056%2520in%2520Reducing%2520Levodopa-Induced%2520Dyskinesia%2520in%2520Patients%2520with%2520Parkinson%25E2%2580%2599s%2520Disease%26spage%3DLB-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingenhöhl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoehr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flor, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vranesic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biollaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allgeier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckendorn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacaan, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santori, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R.</span><span> </span><span class="NLM_article-title">2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a Potent, Selective and Systemically Active mGluR5 Receptor Antagonist</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1493-1503&author=F.+Gaspariniauthor=K.+Lingenh%C3%B6hlauthor=N.+Stoehrauthor=P.+J.+Florauthor=M.+Heinrichauthor=I.+Vranesicauthor=M.+Biollazauthor=H.+Allgeierauthor=R.+Heckendornauthor=S.+Urwylerauthor=M.+A.+Varneyauthor=E.+C.+Johnsonauthor=S.+D.+Hessauthor=S.+P.+Raoauthor=A.+I.+Sacaanauthor=E.+M.+Santoriauthor=G.+Velicelebiauthor=R.+Kuhn&title=2-Methyl-6-%28phenylethynyl%29-pyridine+%28MPEP%29%2C+a+Potent%2C+Selective+and+Systemically+Active+mGluR5+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DLingenh%25C3%25B6hl%26aufirst%3DK.%26aulast%3DStoehr%26aufirst%3DN.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DBiollaz%26aufirst%3DM.%26aulast%3DAllgeier%26aufirst%3DH.%26aulast%3DHeckendorn%26aufirst%3DR.%26aulast%3DUrwyler%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DE.%2BC.%26aulast%3DHess%26aufirst%3DS.%2BD.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DSacaan%26aufirst%3DA.%2BI.%26aulast%3DSantori%26aufirst%3DE.%2BM.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DKuhn%26aufirst%3DR.%26atitle%3D2-Methyl-6-%2528phenylethynyl%2529-pyridine%2520%2528MPEP%2529%252C%2520a%2520Potent%252C%2520Selective%2520and%2520Systemically%2520Active%2520mGluR5%2520Receptor%2520Antagonist%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1493%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">For recent reviews on small molecule antagonists of mGluR5, see:</p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Mancilla, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">mGluR5 Antagonists: Discovery, Characterization and Drug Development</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=18729017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=655-665&author=F.+Gaspariniauthor=G.+Bilbeauthor=B.+Gomez-Mancillaauthor=W.+Spooren&title=mGluR5+Antagonists%3A+Discovery%2C+Characterization+and+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">mGluR5 antagonists: discovery, characterization and drug development</span></div><div class="casAuthors">Gasparini, Fabrizio; Bilbe, Graeme; Gomez-Mancilla, Baltazar; Spooren, Will</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-665</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Disturbances of glutamate-mediated neurotransmission have been implicated in a broad range of nervous system disorders.  Numerous attempts to correct nervous system dysfunction by pharmacol. intervention at glutamate receptors have been made, and some of the approaches have achieved a high level of preclin. validation.  However, in a no. of cases involving agents acting as blockers of the ionotropic glutamate receptors, clin. success could not be achieved, mostly because of the lack of a therapeutic window.  The identification of the metabotropic glutamate receptor (mGluR) family and their modulatory role in the control of neurotransmission provided a new means to alter glutamatergic transmission.  Furthermore, selective agents acting as allosteric antagonists at the mGluR5 subtype have demonstrated therapeutic potential.  The identification and characterization of mGluR5 antagonists and recent progress in clin. development are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox2OH93uxCzbVg90H21EOLACvtfcHk0ljHcMokJu3NCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7nO&md5=cce30e9f299498315c4d2799f43bf4e3</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DmGluR5%2520Antagonists%253A%2520Discovery%252C%2520Characterization%2520and%2520Drug%2520Development%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D655%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordquist, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">mGluR5 Receptor Antagonists and Their Therapeutic Potential</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1517%2F13543776.18.2.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitleksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=123-142&author=G.+Jaeschkeauthor=J.+G.+Wettsteinauthor=R.+E.+Nordquistauthor=W.+Spooren&title=mGluR5+Receptor+Antagonists+and+Their+Therapeutic+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">mGlu5 receptor antagonists and their therapeutic potential</span></div><div class="casAuthors">Jaeschke, Georg; Wettstein, Joseph G.; Nordquist, Rebecca E.; Spooren, Will</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-142</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Glutamate mediates its effects via ionotropic and metabotropic glutamate (mGlu) receptors. mGlu receptors are G protein-coupled receptors that are classified into three clusters, group I-III.  This review focuses on the mGlu5 receptors of group I. mGlu5 receptors are highly expressed in limbic brain regions and are located postsynaptically.  Objective: Following the discovery of the prototypical neg. allosteric modulator MPEP, the therapeutic potential of mGlu5 receptors has been steadily explored and expanded.  This review highlights present developments in drug discovery and the therapeutic potential of neg. allosteric modulators.  Methods: Material evaluated ranged from patents to published literature, but also included information that is available from public-accessible websites.  Results/conclusion: Based on the wide and consistent effects of prototypical antagonists, such as MPEP, it is concluded that mGlu5 receptor antagonists have treatment potential for both peripheral and central nervous system disorders ranging from psychiatric, neurol. to neuromuscular, including illnesses with no apparent nervous system link, such as cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqANYNwRmVlq7Vg90H21EOLACvtfcHk0liqmOC0NwGM2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitleksro%253D&md5=41d6942174211f8ade65b976021fc637</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.2.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.2.123%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DNordquist%26aufirst%3DR.%2BE.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DmGluR5%2520Receptor%2520Antagonists%2520and%2520Their%2520Therapeutic%2520Potential%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2008%26volume%3D18%26spage%3D123%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rodriquez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Allosteric Modulators of mGluR5</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=715-722&author=A.+L.+Rodriquezauthor=R.+Williams&title=Recent+Progress+in+the+Development+of+Allosteric+Modulators+of+mGluR5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriquez%26aufirst%3DA.%2BL.%26aulast%3DWilliams%26aufirst%3DR.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Allosteric%2520Modulators%2520of%2520mGluR5%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D715%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slassi, A.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptor 5 Modulators and Their Potential Therapeutic Applications</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1517%2F13543776.17.4.371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1ertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=371-384&author=P.+Bachauthor=M.+Isaacauthor=A.+Slassi&title=Metabotropic+Glutamate+Receptor+5+Modulators+and+Their+Potential+Therapeutic+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications</span></div><div class="casAuthors">Bach, Peter; Isaac, Methvin; Slassi, Abdelmalik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-384</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Extensive research into the functions of glutamate and glutamate receptors in the CNS has shown an essential role of metabotropic glutamate (mGlu) receptors not only in normal brain functions but also in neurol. and psychiatric disorders.  The precise functions of these receptors remain undefined and progress toward understanding their functions had been hampered by the lack of selective ligands with appropriate pharmacokinetic properties.  The Group I mGlu receptors, comprising mGlu1 and mGlu5 receptors, are well positioned to regulate and fine-tune neuronal excitability and synaptic transmission through its modulation of various signal transduction pathways and interactions with other transmitter systems.  Therefore, the mGlu5 receptor may be an important therapeutic target for the treatment of disorders of the CNS.  The discovery of MPEP, a non-competitive mGluR5 antagonist, provided a potent, selective, systemically active tool compd. for proof-of-concept studies in animal models of various disease states.  Considerable advances have been made since the applications of glutamate receptor modulators was reviewed by Sabbatini and Micheli in this journal in late 2004.  Most intriguing is the increased understanding of the mechanism and pathophysiol. of mGlu5 receptors in the treatment of CNS diseases.  The importance of mGlu5 receptors is manifested by the growing nos. of patents filed and scientific papers published in recent years.  In the present patent review, compd. series have been categorized as antagonists/inhibitors or modulators/potentiators, according to the claims in the resp. patent applications.  Claims that relate to and specify group I mGluRs have been included in a sep. section, while claims for specified compd. series for the treatment of glutamate receptor-mediated disorders in general have not been included.  Primary literature has been referenced when information on compd. series from the patent literature could be supplemented with, for example, SAR or pharmacol. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQia1cTnEobVg90H21EOLACvtfcHk0liqmOC0NwGM2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1ertLs%253D&md5=ddf617b337a327bc5ee933d88bfc83eb</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.4.371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.4.371%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DP.%26aulast%3DIsaac%26aufirst%3DM.%26aulast%3DSlassi%26aufirst%3DA.%26atitle%3DMetabotropic%2520Glutamate%2520Receptor%25205%2520Modulators%2520and%2520Their%2520Potential%2520Therapeutic%2520Applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2007%26volume%3D17%26spage%3D371%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Pecknold, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appeltauer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrzesinski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, T.</span><span> </span><span class="NLM_article-title">Treatment of Anxiety Using Fenobam (a Nonbenzodiazepine) in a Double-Blind Standard (Diazepam) Placebo-Controlled Study</span> <span class="citation_source-journal">J. Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A280%3ADyaL387ptVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1982&pages=129-133&author=J.+C.+Pecknoldauthor=D.+J.+McClureauthor=L.+Appeltauerauthor=L.+Wrzesinskiauthor=T.+Allan&title=Treatment+of+Anxiety+Using+Fenobam+%28a+Nonbenzodiazepine%29+in+a+Double-Blind+Standard+%28Diazepam%29+Placebo-Controlled+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study</span></div><div class="casAuthors">Pecknold J C; McClure D J; Appeltauer L; Wrzesinski L; Allan T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-33</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLFJ-67ZItf4NpW7w2tapOfW6udTcc2eZ956VR6gx5grntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL387ptVCqtA%253D%253D&md5=500b6039321f24462ab3fd1985560fea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPecknold%26aufirst%3DJ.%2BC.%26aulast%3DMcClure%26aufirst%3DD.%2BJ.%26aulast%3DAppeltauer%26aufirst%3DL.%26aulast%3DWrzesinski%26aufirst%3DL.%26aulast%3DAllan%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520Anxiety%2520Using%2520Fenobam%2520%2528a%2520Nonbenzodiazepine%2529%2520in%2520a%2520Double-Blind%2520Standard%2520%2528Diazepam%2529%2520Placebo-Controlled%2520Study%26jtitle%3DJ.%2520Clin.%2520Neuropharmacol.%26date%3D1982%26volume%3D2%26spage%3D129%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mühlemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenobam, A</span><span> </span><span class="NLM_article-title">Clinically Validated Nonbenzodiazepine Anxiolytic is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1124%2Fjpet.105.089839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=16040814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=711-721&author=R.+H.+P.+Porterauthor=G.+Jaeschkeauthor=W.+Spoorenauthor=T.+M.+Ballardauthor=B.+B%C3%BCttelmannauthor=S.+Kolczewskiauthor=J.-U.+Petersauthor=E.+Prinssenauthor=J.+Wichmannauthor=E.+Vieiraauthor=A.+M%C3%BChlemannauthor=S.+Gattiauthor=V.+Mutelauthor=P.+Malherbeauthor=A+Fenobam&title=Clinically+Validated+Nonbenzodiazepine+Anxiolytic+is+a+Potent%2C+Selective%2C+and+Noncompetitive+mGlu5+Receptor+Antagonist+with+Inverse+Agonist+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fenobam: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity</span></div><div class="casAuthors">Porter, Richard H. P.; Jaeschke, Georg; Spooren, Will; Ballard, Theresa M.; Buttelmann, Bernd; Kolczewski, Sabine; Peters, Jens-Uwe; Prinseen, Eric; Wichmann, Jurgen; Vieira, Eric; Muhlemann, Andreas; Gatti, Silvia; Mutel, Vincent; Malherbe, Pari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">711-721</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea] is an atypical anxiolytic agent with unknown mol. target that has previously been demonstrated both in rodents and human to exert anxiolytic activity.  Here, we report that fenobam is a selective and potent metabotropic glutamate (mGlu)5 receptor antagonist acting at an allosteric modulatory site shared with 2-methyl-6-phenylethynyl-pyridine (MPEP), the protypical selective mGlu5 receptor antagonist.  Fenobam inhibited quisqualate-evoked intracellular calcium response mediated by human mGlu5 receptor with IC50 = 58±2 nM.  It acted in a noncompetitive manner, similar to MPEP and demonstrated inverse agonist properties, blocking 66% of the mGlu5 receptor basal activity (in an over expressed cell line) with an IC50 = 84±13 nM.  [3H]Fenobam bound to rat and human recombinant receptors with Kd values of 54±6 and 31±4 nM, resp.  MPEP inhibited [3H]fenobam binding to human mGlu5 receptors with a Ki value of 6.7±0.7 nM, indicating a common binding site shared by both allosteric antagonists.  Fenobam exhibits anxiolytic activity in the stress-induced hyperthermia model, Vogel conflict test, Geller-Seifter conflict test, and conditioned emotional response with a min. ED of 10 to 30 mg/kg p.o.  Furthermore, fenobam is devoid of GABAergic activity, confirming previous reports that fenobam acts by a mechanism distinct from benzodiazepines.  The non-GABAergic activity of fenobam, coupled with its robust anxiolytic activity and reported efficacy in human in a double blind placebo-controlled trial, supports the potential of developing mGlu5 receptor antagonists with an improved therapeutic window over benzodiazepines as novel anxiolytic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQg1qRiOD0cLVg90H21EOLACvtfcHk0ljAnjJK2zySxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F&md5=8d08eb1e3f777231204024da12301a2e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089839%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DBallard%26aufirst%3DT.%2BM.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DM%25C3%25BChlemann%26aufirst%3DA.%26aulast%3DGatti%26aufirst%3DS.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DFenobam%26aufirst%3DA%26atitle%3DClinically%2520Validated%2520Nonbenzodiazepine%2520Anxiolytic%2520is%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Noncompetitive%2520mGlu5%2520Receptor%2520Antagonist%2520with%2520Inverse%2520Agonist%2520Activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D711%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gasparini, F.; Auberson, Y.; Ofner, S.</span><span> </span><span class="NLM_article-title">Acetylene Derivatives Having mGluR5 Antagonistic Activity</span>. Patent PCT/WO03/047581A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=F.+Gasparini&author=Y.+Auberson&author=S.+Ofner&title=Acetylene+Derivatives+Having+mGluR5+Antagonistic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DAcetylene%2520Derivatives%2520Having%2520mGluR5%2520Antagonistic%2520Activity%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Roppe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehrani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Discovery of Novel Heteroarylazoles that are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4645</span><span class="NLM_x">–</span> <span class="NLM_lpage">4648</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049828c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4645-4648&author=J.+Roppeauthor=N.+D.+Smithauthor=D.+Huangauthor=L.+Tehraniauthor=B.+Wangauthor=J.+Andersonauthor=J.+Brodkinauthor=J.+Chungauthor=X.+Jiangauthor=C.+Kingauthor=B.+Munozauthor=M.+A.+Varneyauthor=P.+Prasitauthor=N.+D.+P.+Cosford&title=Discovery+of+Novel+Heteroarylazoles+that+are+Metabotropic+Glutamate+Subtype+5+Receptor+Antagonists+with+Anxiolytic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm049828c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049828c%26sid%3Dliteratum%253Aachs%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDiscovery%2520of%2520Novel%2520Heteroarylazoles%2520that%2520are%2520Metabotropic%2520Glutamate%2520Subtype%25205%2520Receptor%2520Antagonists%2520with%2520Anxiolytic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4645%26epage%3D4648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hall, S. E.; Ballas, L. M.; Kulanthaivel, P.; Boros, C.; Jiang, J. B.; Jagdmann, G. E.,  Jr.; Lai, Y.-S.; Biggers, C. K.; Hu, H.; Hallock, Y.; Hughes, P. F.; Defauw, J. M.; Lynch, M. P.; Lampe, J. W. C.; Menaldino, D. S.; Heerding, J. M.; Janzen, W. P.; Hollinshead, S. P.</span> Balanoids. Patent PCT/WO94/20062A2<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hall%2C+S.+E.%3B+Ballas%2C+L.+M.%3B+Kulanthaivel%2C+P.%3B+Boros%2C+C.%3B+Jiang%2C+J.+B.%3B+Jagdmann%2C+G.+E.%2C+Jr.%3B+Lai%2C+Y.-S.%3B+Biggers%2C+C.+K.%3B+Hu%2C+H.%3B+Hallock%2C+Y.%3B+Hughes%2C+P.+F.%3B+Defauw%2C+J.+M.%3B+Lynch%2C+M.+P.%3B+Lampe%2C+J.+W.+C.%3B+Menaldino%2C+D.+S.%3B+Heerding%2C+J.+M.%3B+Janzen%2C+W.+P.%3B+Hollinshead%2C+S.+P.+Balanoids.+Patent+PCT%2FWO94%2F20062A2+1994."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DS.%2BE.%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Lai, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mylott, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Ring Size Effects in the PKC Inhibitory Activities of Perhydroazepine Analogs of Balanol</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2151-2154&author=Y.-S.+Laiauthor=D.+S.+Menaldinoauthor=J.+B.+Nicholsauthor=G.+E.+Jagdmannauthor=F.+Mylottauthor=J.+Gillespieauthor=S.+E.+Hall&title=Ring+Size+Effects+in+the+PKC+Inhibitory+Activities+of+Perhydroazepine+Analogs+of+Balanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.-S.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DNichols%26aufirst%3DJ.%2BB.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DMylott%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DRing%2520Size%2520Effects%2520in%2520the%2520PKC%2520Inhibitory%2520Activities%2520of%2520Perhydroazepine%2520Analogs%2520of%2520Balanol%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D2151%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ashton, W. T.; Caldwell, C. G.; Mathvink, R. J.; Ok, H. O.; Reigle, L. B.; Weber, A. E.</span><span> </span><span class="NLM_article-title">Preparation of 3-Amino-4-phenylbutanoic acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes</span>. Patent PCT/WO2004/064778A2<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+T.+Ashton&author=C.+G.+Caldwell&author=R.+J.+Mathvink&author=H.+O.+Ok&author=L.+B.+Reigle&author=A.+E.+Weber&title=Preparation+of+3-Amino-4-phenylbutanoic+acid+Derivatives+as+Dipeptidyl+Peptidase+Inhibitors+for+the+Treatment+or+Prevention+of+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DW.%2BT.%26atitle%3DPreparation%2520of%25203-Amino-4-phenylbutanoic%2520acid%2520Derivatives%2520as%2520Dipeptidyl%2520Peptidase%2520Inhibitors%2520for%2520the%2520Treatment%2520or%2520Prevention%2520of%2520Diabetes%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gordon, T. B.; Morgan, B. A.</span><span> </span><span class="NLM_article-title">Prenyl Transferase Inhibitors</span>. Patent PCT/WO2000/039130A2<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=T.+B.+Gordon&author=B.+A.+Morgan&title=Prenyl+Transferase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DT.%2BB.%26atitle%3DPrenyl%2520Transferase%2520Inhibitors%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikugawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.-I.</span><span> </span><span class="NLM_article-title">Chemistry of Diborane and Sodium Borohydride. VIII. Imidate Formation from Nitriles with Sodium Borohydride</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1973&pages=465-472&author=H.+Watanabeauthor=Y.+Kikugawaauthor=S.-I.+Yamada&title=Chemistry+of+Diborane+and+Sodium+Borohydride.+VIII.+Imidate+Formation+from+Nitriles+with+Sodium+Borohydride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKikugawa%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DS.-I.%26atitle%3DChemistry%2520of%2520Diborane%2520and%2520Sodium%2520Borohydride.%2520VIII.%2520Imidate%2520Formation%2520from%2520Nitriles%2520with%2520Sodium%2520Borohydride%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1973%26volume%3D21%26spage%3D465%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Borchardt, A. J.; Kahraman, M.; Cook, T. G.; Davis, R. L.; Gardiner, E. M. M.; Malecha, J. W.; Noble, S. A.; Prins, T. J.; Sertic, M.; Siegel, D. L.</span><span> </span><span class="NLM_article-title">Heteroaryl Inhibitors of Rho Kinase</span>. Patent PCT/WO2008/011557A2<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+J.+Borchardt&author=M.+Kahraman&author=T.+G.+Cook&author=R.+L.+Davis&author=E.+M.+M.+Gardiner&author=J.+W.+Malecha&author=S.+A.+Noble&author=T.+J.+Prins&author=M.+Sertic&author=D.+L.+Siegel&title=Heteroaryl+Inhibitors+of+Rho+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DA.%2BJ.%26atitle%3DHeteroaryl%2520Inhibitors%2520of%2520Rho%2520Kinase%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lai, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggers, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, L. M.</span><span> </span><span class="NLM_article-title">Synthesis and Protein Kinase C Inhibitory Activities of Balanol Analogs with Replacement of the Perhydroazepine Moiety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960497g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=226-235&author=Y.-S.+Laiauthor=J.+S.+Mendozaauthor=G.+E.+Jagdmannauthor=D.+S.+Menaldinoauthor=C.+K.+Biggersauthor=J.+M.+Heerdingauthor=J.+W.+Wilsonauthor=S.+E.+Hallauthor=J.+B.+Jiangauthor=W.+P.+Janzenauthor=L.+M.+Ballas&title=Synthesis+and+Protein+Kinase+C+Inhibitory+Activities+of+Balanol+Analogs+with+Replacement+of+the+Perhydroazepine+Moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm960497g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960497g%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.-S.%26aulast%3DMendoza%26aufirst%3DJ.%2BS.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DBiggers%26aufirst%3DC.%2BK.%26aulast%3DHeerding%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DS.%2BE.%26aulast%3DJiang%26aufirst%3DJ.%2BB.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DBallas%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520and%2520Protein%2520Kinase%2520C%2520Inhibitory%2520Activities%2520of%2520Balanol%2520Analogs%2520with%2520Replacement%2520of%2520the%2520Perhydroazepine%2520Moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D226%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Dupriez, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgeon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detheux, M.</span><span> </span><span class="NLM_article-title">Aequorin-Based Functional Assays for G-Protein-Coupled Receptors, Ion Channels, and Tyrosine Kinase Receptors</span> <span class="citation_source-journal">Recept. Channels</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1080%2F10606820214646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=12690959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVCrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=319-330&author=V.+J.+Dupriezauthor=K.+Maesauthor=E.+Le+Poulauthor=E.+Burgeonauthor=M.+Detheux&title=Aequorin-Based+Functional+Assays+for+G-Protein-Coupled+Receptors%2C+Ion+Channels%2C+and+Tyrosine+Kinase+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aequorin-based functional assays for G-protein-coupled receptors, ion channels and tyrosine kinase receptors</span></div><div class="casAuthors">Dupriez, Vincent J.; Maes, Karlien; Le Poul, Emmanuel; Burgeon, Emmanuel; Detheux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Receptors and Channels</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">RCHAE4</span>;
        ISSN:<span class="NLM_cas:issn">1060-6823</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Aequorin is a photoprotein originating from jellyfish, whose luminescent activity is dependent on the concn. of calcium ions.  Due to the high sensitivity and low background linked to luminescent assays, as well as to its absence of toxicity and its large linear dynamic range, aequorin has been used as an intracellular calcium indicator since its discovery in the early 1960s.  The first applications of aequorin involved its microinjection in cells.  The cloning of its gene in 1985 opened the way to the stable expression of aequorin in cell lines or even entire organisms.  Here the authors present the validation of aequorin as a functional assay for the screening of G-protein-coupled receptors, ion channels, and tyrosine kinase receptors, as well as for their pharmacol. characterization in agonist and antagonist detection assays.  The authors optimized the authors' cell suspension-based assay and detd. that the most sensitive assay was performed at room temp., with mitochondrially expressed aequorin and using coelenterazine deriv. h for reconstitution of aequorin.  The robustness of the assay and the current availability of luminometers with integrated injectors allow aequorin to fit perfectly with high throughput functional assays requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrceQj9SnumELVg90H21EOLACvtfcHk0lgziKqKZoB41Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVCrsLg%253D&md5=341940fbd1b156099223fc5de42debeb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F10606820214646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10606820214646%26sid%3Dliteratum%253Aachs%26aulast%3DDupriez%26aufirst%3DV.%2BJ.%26aulast%3DMaes%26aufirst%3DK.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DBurgeon%26aufirst%3DE.%26aulast%3DDetheux%26aufirst%3DM.%26atitle%3DAequorin-Based%2520Functional%2520Assays%2520for%2520G-Protein-Coupled%2520Receptors%252C%2520Ion%2520Channels%252C%2520and%2520Tyrosine%2520Kinase%2520Receptors%26jtitle%3DRecept.%2520Channels%26date%3D2002%26volume%3D8%26spage%3D319%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochvil, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhlemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenner, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span> </span><span class="NLM_article-title">Comparison of the Binding Pockets of Two Chemically Unrelated Allosteric Antagonists of the mGluR5 Receptor and Identification of Crucial Resudues Involved in the Inverse Agonism of MPEP</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1111%2Fj.1471-4159.2006.03886.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=16805850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Omsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=601-615&author=P.+Malherbeauthor=N.+Kratochvilauthor=A.+Muhlemannauthor=M.-T.+Zennerauthor=C.+Fischerauthor=M.+Stahlauthor=P.+R.+Gerberauthor=G.+Jaeschkeauthor=R.+H.+P.+Porter&title=Comparison+of+the+Binding+Pockets+of+Two+Chemically+Unrelated+Allosteric+Antagonists+of+the+mGluR5+Receptor+and+Identification+of+Crucial+Resudues+Involved+in+the+Inverse+Agonism+of+MPEP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP</span></div><div class="casAuthors">Malherbe, Pari; Kratochwil, Nicole; Muhlemann, Andreas; Zenner, Marie-Therese; Fischer, Christophe; Stahl, Martin; Gerber, Paul R.; Jaeschke, Georg; Porter, Richard H. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">601-615</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Fenobam, a clin. validated non-benzodiazepine anxiolytic, has been shown to be a potent and non-competitive metabotropic glutamate (mGlu)-5 receptor antagonist.  In the present study, we have used the site-directed mutagenesis coupled with three-dimensional receptor-based pharmacophore modeling to elucidate the interacting mode of fenobam within the seven-transmembrane domain (7TMD) of mGlu5 receptor and its comparison with that of 2-methyl-6-(phenylethynyl)pyridine (MPEP), the prototype antagonist.  The common residues involved in the recognition of MPEP and fenobam include Pro6543.36, Tyr6583.40, Thr7806.44, Trp7846.48, Phe7876.51, Tyr7916.55 and Ala8097.47.  The differentiating residues between both modulators' interacting modes are Arg6473.29, Ser6573.39 and Leu7435.47.  Our data suggest that these chem. unrelated mGlu5 antagonists act similarly, probing a functionally unique region of the 7TMD.  Using [3H]inositol phosphates accumulation assay, we have also identified the crit. residues involved in the inverse agonist effect of MPEP.  The mutation W7846.48A completely blocked the inverse agonist activity of MPEP; two mutations F7876.51A and Y7916.55A, caused a drastic decrease in the MPEP inverse agonism.  Furthermore, these three mutations led to an increased efficacy of quisqualate without having any effect on its potency.  The fact that the residues Trp7846.48 and Phe7876.51 are essential equally in antagonism and inverse agonism effects emphasizes again the key role of these residues and the involvement of a common transmembrane network in receptor inactivation by MPEP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwIir19e3p67Vg90H21EOLACvtfcHk0lgziKqKZoB41Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Omsbw%253D&md5=18ddced8d4d9840427a0c529773dd8a9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03886.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03886.x%26sid%3Dliteratum%253Aachs%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DKratochvil%26aufirst%3DN.%26aulast%3DMuhlemann%26aufirst%3DA.%26aulast%3DZenner%26aufirst%3DM.-T.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DGerber%26aufirst%3DP.%2BR.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26atitle%3DComparison%2520of%2520the%2520Binding%2520Pockets%2520of%2520Two%2520Chemically%2520Unrelated%2520Allosteric%2520Antagonists%2520of%2520the%2520mGluR5%2520Receptor%2520and%2520Identification%2520of%2520Crucial%2520Resudues%2520Involved%2520in%2520the%2520Inverse%2520Agonism%2520of%2520MPEP%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D98%26spage%3D601%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Johnston, M. J.; Fox, S. H.; McIldowie, M. J.; Piggott, M. J.; Brotchie, J. M.</span><span> </span><span class="NLM_article-title">Antidyskinetic Effects of the Selective Metabotropic Glutamate Receptor 5 (mGluR5) Antagonist MTEP in the MPTP-lesioned Macaque Model of Parkinson’s Disease</span>. Presented at the <span class="NLM_conf-name">Society for Neuroscience Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">October 17−21, 2009</span>;  <span class="NLM_fpage">530.19</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Johnston%2C+M.+J.%3B+Fox%2C+S.+H.%3B+McIldowie%2C+M.+J.%3B+Piggott%2C+M.+J.%3B+Brotchie%2C+J.+M.+Antidyskinetic+Effects+of+the+Selective+Metabotropic+Glutamate+Receptor+5+%28mGluR5%29+Antagonist+MTEP+in+the+MPTP-lesioned+Macaque+Model+of+Parkinson%E2%80%99s+Disease.+Presented+at+the+Society+for+Neuroscience+Meeting%2C+Chicago%2C+IL%2C+October+17%E2%88%9221%2C+2009%3B+530.19."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DM.%2BJ.%26atitle%3DAntidyskinetic%2520Effects%2520of%2520the%2520Selective%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520%2528mGluR5%2529%2520Antagonist%2520MTEP%2520in%2520the%2520MPTP-lesioned%2520Macaque%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26spage%3D530.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 20 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Daniel W. Widlicka, Alexander Gontcharov, Ruchi Mehta, Dylan J. Pedro, <span class="NLM_string-name hlFld-ContribAuthor">Robert North</span>. </span><span class="cited-content_cbyCitation_article-title">Enantiospecific Synthesis of (3R,4R)-1-Benzyl-4-fluoropyrrolidin-3-amine Utilizing a Burgess-Type Transformation. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2019,</strong> <em>23 </em>
                                    (9)
                                     , 1970-1978. <a href="https://doi.org/10.1021/acs.oprd.9b00245" title="DOI URL">https://doi.org/10.1021/acs.oprd.9b00245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.9b00245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.9b00245%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEnantiospecific%252BSynthesis%252Bof%252B%2525283R%25252C4R%252529-1-Benzyl-4-fluoropyrrolidin-3-amine%252BUtilizing%252Ba%252BBurgess-Type%252BTransformation%26aulast%3DWidlicka%26aufirst%3DDaniel%2BW.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D31072019%26date%3D16072019%26volume%3D23%26issue%3D9%26spage%3D1970%26epage%3D1978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula  Ruiz-Castillo</span> and <span class="hlFld-ContribAuthor ">Stephen L.  Buchwald</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (19)
                                     , 12564-12649. <a href="https://doi.org/10.1021/acs.chemrev.6b00512" title="DOI URL">https://doi.org/10.1021/acs.chemrev.6b00512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.6b00512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.6b00512%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DApplications%252Bof%252BPalladium-Catalyzed%252BC%2525E2%252580%252593N%252BCross-Coupling%252BReactions%26aulast%3DRuiz-Castillo%26aufirst%3DPaula%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D03082016%26date%3D30092016%26date%3D12102016%26volume%3D116%26issue%3D19%26spage%3D12564%26epage%3D12649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aileen  Healy</span>, <span class="hlFld-ContribAuthor ">Roger  Rush</span>, and <span class="hlFld-ContribAuthor ">Timothy  Ocain</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragile X Syndrome: An Update on Developing Treatment Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2011,</strong> <em>2 </em>
                                    (8)
                                     , 402-410. <a href="https://doi.org/10.1021/cn200019z" title="DOI URL">https://doi.org/10.1021/cn200019z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn200019z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn200019z%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DFragile%252BX%252BSyndrome%25253A%252BAn%252BUpdate%252Bon%252BDeveloping%252BTreatment%252BModalities%26aulast%3DHealy%26aufirst%3DAileen%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D02032011%26date%3D22032011%26date%3D01042011%26date%3D17082011%26date%3D22032011%26volume%3D2%26issue%3D8%26spage%3D402%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>  . </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Design and Development of Novel Negative Allosteric Modulators of mGlu5. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2011,</strong> <em>2 </em>
                                    (8)
                                     , 411-432. <a href="https://doi.org/10.1021/cn2000266" title="DOI URL">https://doi.org/10.1021/cn2000266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cn2000266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcn2000266%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDesign%252Band%252BDevelopment%252Bof%252BNovel%252BNegative%252BAllosteric%252BModulators%252Bof%252BmGlu5%26aulast%3DEmmitte%26aufirst%3DKyle%2BA.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D15032011%26date%3D15042011%26date%3D29042011%26date%3D17082011%26date%3D15042011%26volume%3D2%26issue%3D8%26spage%3D411%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuliya O.  Kuchkovska</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Azepines and Their Fused-Ring Derivatives. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00073-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00073-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00073-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00073-1%26sid%3Dliteratum%253Aachs%26atitle%3DAzepines%252Band%252BTheir%252BFused-Ring%252BDerivatives%26aulast%3DKuchkovska%26aufirst%3DYuliya%2BO.%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Ramesh  Sistla</span>. </span><span class="cited-content_cbyCitation_article-title">A survey of applications of tetrahydropyrrolo-3,4-azoles and tetrahydropyrrolo-2,3-azoles in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 31-100. <a href="https://doi.org/10.1016/bs.aihch.2020.10.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2020.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2020.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2020.10.004%26sid%3Dliteratum%253Aachs%26atitle%3DA%252Bsurvey%252Bof%252Bapplications%252Bof%252Btetrahydropyrrolo-3%25252C4-azoles%252Band%252Btetrahydropyrrolo-2%25252C3-azoles%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26spage%3D31%26epage%3D100%26pub%3DElsevier%26atitle%3DApplications%252Bof%252BHeterocycles%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252Band%252BAgricultural%252BProducts%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olivier  Lorthioir</span>, <span class="hlFld-ContribAuthor ">Ryan D.  Greenwood</span>, <span class="hlFld-ContribAuthor ">Andrew  Lister</span>, <span class="hlFld-ContribAuthor ">Michael J.  Tucker</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient and flexible route to novel triazolopiperazine scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (50)
                                     , 152600. <a href="https://doi.org/10.1016/j.tetlet.2020.152600" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.152600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.152600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.152600%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Band%252Bflexible%252Broute%252Bto%252Bnovel%252Btriazolopiperazine%252Bscaffolds%26aulast%3DLorthioir%26aufirst%3DOlivier%26date%3D2020%26volume%3D61%26issue%3D50%26spage%3D152600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hannah L.  Stewart</span>, <span class="hlFld-ContribAuthor ">Abigail R.  Hanby</span>, <span class="hlFld-ContribAuthor ">Thomas A.  King</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Bond</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Moss</span>, <span class="hlFld-ContribAuthor ">Hannah F.  Sore</span>, <span class="hlFld-ContribAuthor ">David R.  Spring</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient, stereocontrolled and versatile synthetic route to bicyclic partially saturated privileged scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (50)
                                     , 6818-6821. <a href="https://doi.org/10.1039/D0CC02728F" title="DOI URL">https://doi.org/10.1039/D0CC02728F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC02728F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC02728F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DAn%252Befficient%25252C%252Bstereocontrolled%252Band%252Bversatile%252Bsynthetic%252Broute%252Bto%252Bbicyclic%252Bpartially%252Bsaturated%252Bprivileged%252Bscaffolds%26aulast%3DStewart%26aufirst%3DHannah%2BL.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D50%26spage%3D6818%26epage%3D6821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evgeniy Y.  Slobodyanyuk</span>, <span class="hlFld-ContribAuthor ">Yulia L.  Berezowska</span>, <span class="hlFld-ContribAuthor ">Vitaliy V.  Solomin</span>, <span class="hlFld-ContribAuthor ">Dmitriy M.  Volochnyuk</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Rozhenko</span>, <span class="hlFld-ContribAuthor ">Sergey V.  Ryabukhin</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Formation of 10/12/14-Membered Rings is Favored over 5/6/7-Membered. An Unexpected Result from Oxazole Chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (30)
                                     , 4962-4967. <a href="https://doi.org/10.1002/ejoc.201900914" title="DOI URL">https://doi.org/10.1002/ejoc.201900914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900914%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFormation%252Bof%252B10%25252F12%25252F14-Membered%252BRings%252Bis%252BFavored%252Bover%252B5%25252F6%25252F7-Membered.%252BAn%252BUnexpected%252BResult%252Bfrom%252BOxazole%252BChemistry%26aulast%3DSlobodyanyuk%26aufirst%3DEvgeniy%2BY.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D30%26spage%3D4962%26epage%3D4967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yandong  Lu</span>, <span class="hlFld-ContribAuthor ">Shan  Zhao</span>, <span class="hlFld-ContribAuthor ">Shijie  Zhou</span>, <span class="hlFld-ContribAuthor ">Si-Cong  Chen</span>, <span class="hlFld-ContribAuthor ">Tuoping  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective syntheses and application of 4-
              epi
              -galiellalactone and the corresponding activity-based probe: from strained bicycles to strained tricycles. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2019,</strong> <em>17 </em>
                                    (7)
                                     , 1886-1892. <a href="https://doi.org/10.1039/C8OB01915K" title="DOI URL">https://doi.org/10.1039/C8OB01915K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01915K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01915K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DEnantioselective%252Bsyntheses%252Band%252Bapplication%252Bof%252B4-%252Bepi%252B-galiellalactone%252Band%252Bthe%252Bcorresponding%252Bactivity-based%252Bprobe%25253A%252Bfrom%252Bstrained%252Bbicycles%252Bto%252Bstrained%252Btricycles%26aulast%3DLu%26aufirst%3DYandong%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D7%26spage%3D1886%26epage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wataru  Hirose</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Kato</span>, <span class="hlFld-ContribAuthor ">Itaru  Natsutani</span>, <span class="hlFld-ContribAuthor ">Makoto  Takata</span>, <span class="hlFld-ContribAuthor ">Maiko  Kitaichi</span>, <span class="hlFld-ContribAuthor ">Satoki  Imai</span>, <span class="hlFld-ContribAuthor ">Shun  Hayashi</span>, <span class="hlFld-ContribAuthor ">Yukiyo  Arai</span>, <span class="hlFld-ContribAuthor ">Kohei  Hoshino</span>, <span class="hlFld-ContribAuthor ">Kohzo  Yoshida</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c]pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4331-4335. <a href="https://doi.org/10.1016/j.bmcl.2017.08.030" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Boptimization%252Bof%252B4%25252C5%25252C6%25252C7-tetrahydrooxazolo%25255B4%25252C5-c%25255Dpyridines%252Bas%252Bpotent%252Band%252Borally-active%252Bmetabotropic%252Bglutamate%252Breceptor%252B5%252Bnegative%252Ballosteric%252Bmodulators%26aulast%3DHirose%26aufirst%3DWataru%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4331%26epage%3D4335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyle A.  Emmitte</span>. </span><span class="cited-content_cbyCitation_article-title">mGlu
              5
              negative allosteric modulators: a patent review (2013 - 2016). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 691-706. <a href="https://doi.org/10.1080/13543776.2017.1280466" title="DOI URL">https://doi.org/10.1080/13543776.2017.1280466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1280466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1280466%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGlu%252B5%252Bnegative%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282013%252B-%252B2016%252529%26aulast%3DEmmitte%26aufirst%3DKyle%2BA.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D691%26epage%3D706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Anighoro</span>, <span class="hlFld-ContribAuthor ">Davide  Graziani</span>, <span class="hlFld-ContribAuthor ">Ilaria  Bettinelli</span>, <span class="hlFld-ContribAuthor ">Antonio  Cilia</span>, <span class="hlFld-ContribAuthor ">Carlo  De Toma</span>, <span class="hlFld-ContribAuthor ">Matteo  Longhi</span>, <span class="hlFld-ContribAuthor ">Fabio  Mangiarotti</span>, <span class="hlFld-ContribAuthor ">Sergio  Menegon</span>, <span class="hlFld-ContribAuthor ">Lorenza  Pirona</span>, <span class="hlFld-ContribAuthor ">Elena  Poggesi</span>, <span class="hlFld-ContribAuthor ">Carlo  Riva</span>, <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: Discovery and computational modeling of a new series of ligands with nanomolar affinity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (13)
                                     , 3040-3058. <a href="https://doi.org/10.1016/j.bmc.2015.05.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252Bthe%252Binteraction%252Bof%252Bnegative%252Ballosteric%252Bmodulators%252Bwith%252Bthe%252Bmetabotropic%252Bglutamate%252Breceptor%252B5%25253A%252BDiscovery%252Band%252Bcomputational%252Bmodeling%252Bof%252Ba%252Bnew%252Bseries%252Bof%252Bligands%252Bwith%252Bnanomolar%252Baffinity%26aulast%3DAnighoro%26aufirst%3DAndrew%26date%3D2015%26volume%3D23%26issue%3D13%26spage%3D3040%26epage%3D3058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taro  Kato</span>, <span class="hlFld-ContribAuthor ">Makoto  Takata</span>, <span class="hlFld-ContribAuthor ">Maiko  Kitaichi</span>, <span class="hlFld-ContribAuthor ">Momoe  Kassai</span>, <span class="hlFld-ContribAuthor ">Mitsuhiro  Inoue</span>, <span class="hlFld-ContribAuthor ">Chihiro  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Wataru  Hirose</span>, <span class="hlFld-ContribAuthor ">Kozo  Yoshida</span>, <span class="hlFld-ContribAuthor ">Isao  Shimizu</span>. </span><span class="cited-content_cbyCitation_article-title">DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2015,</strong> <em>757 </em>, 11-20. <a href="https://doi.org/10.1016/j.ejphar.2015.03.024" title="DOI URL">https://doi.org/10.1016/j.ejphar.2015.03.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2015.03.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2015.03.024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DDSR-98776%25252C%252Ba%252Bnovel%252Bselective%252BmGlu5%252Breceptor%252Bnegative%252Ballosteric%252Bmodulator%252Bwith%252Bpotent%252Bantidepressant%252Band%252Bantimanic%252Bactivity%26aulast%3DKato%26aufirst%3DTaro%26date%3D2015%26volume%3D757%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guiying  Li</span>, <span class="hlFld-ContribAuthor ">Morten  Jørgensen</span>, <span class="hlFld-ContribAuthor ">Brian M  Campbell</span>. </span><span class="cited-content_cbyCitation_article-title">Metabotropic glutamate receptor 5-negative allosteric modulators for the treatment of psychiatric and neurological disorders (2009–July 2013). </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2013,</strong> <em>2 </em>
                                    (6)
                                     , 767-802. <a href="https://doi.org/10.4155/ppa.13.58" title="DOI URL">https://doi.org/10.4155/ppa.13.58</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.13.58&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.13.58%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DMetabotropic%252Bglutamate%252Breceptor%252B5-negative%252Ballosteric%252Bmodulators%252Bfor%252Bthe%252Btreatment%252Bof%252Bpsychiatric%252Band%252Bneurological%252Bdisorders%252B%2525282009%2525E2%252580%252593July%252B2013%252529%26aulast%3DLi%26aufirst%3DGuiying%26date%3D2013%26volume%3D2%26issue%3D6%26spage%3D767%26epage%3D802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eunhee  Chae</span>, <span class="hlFld-ContribAuthor ">Yong-Je  Shin</span>, <span class="hlFld-ContribAuthor ">Eun-Ju  Ryu</span>, <span class="hlFld-ContribAuthor ">Mi Kyung  Ji</span>, <span class="hlFld-ContribAuthor ">Nahm  Ryune Cho</span>, <span class="hlFld-ContribAuthor ">Ki-Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Hyun Ji  Jeong</span>, <span class="hlFld-ContribAuthor ">Soo-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Yeonjung  Choi</span>, <span class="hlFld-ContribAuthor ">Kyung  Seok Oh</span>, <span class="hlFld-ContribAuthor ">Chun-Eung  Park</span>, <span class="hlFld-ContribAuthor ">Young  Soo Yoon</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (7)
                                     , 2134-2139. <a href="https://doi.org/10.1016/j.bmcl.2013.01.116" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.01.116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.01.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.01.116%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bbiological%252Bevaluation%252Bof%252Bpyrazole%25252Fimidazole%252Bamides%252Bas%252BmGlu5%252Breceptor%252Bnegative%252Ballosteric%252Bmodulators%26aulast%3DChae%26aufirst%3DEunhee%26date%3D2013%26volume%3D23%26issue%3D7%26spage%3D2134%26epage%3D2139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kyle A  Emmitte</span>. </span><span class="cited-content_cbyCitation_article-title">mGlu
              5
              negative allosteric modulators: a patent review (2010 – 2012). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2013,</strong> <em>23 </em>
                                    (4)
                                     , 393-408. <a href="https://doi.org/10.1517/13543776.2013.760544" title="DOI URL">https://doi.org/10.1517/13543776.2013.760544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2013.760544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2013.760544%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DmGlu%252B5%252Bnegative%252Ballosteric%252Bmodulators%25253A%252Ba%252Bpatent%252Breview%252B%2525282010%252B%2525E2%252580%252593%252B2012%252529%26aulast%3DEmmitte%26aufirst%3DKyle%2BA%26date%3D2013%26date%3D2013%26volume%3D23%26issue%3D4%26spage%3D393%26epage%3D408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. N.  Maksimova</span>, <span class="hlFld-ContribAuthor ">O. V.  Ershov</span>, <span class="hlFld-ContribAuthor ">K. V.  Lipin</span>, <span class="hlFld-ContribAuthor ">A. V.  Eremkin</span>, <span class="hlFld-ContribAuthor ">O. E.  Nasakin</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective reaction of 5,6-dialkyl-2-halopyridine-3,4-dicarbonitriles with ammonia. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>48 </em>
                                    (3)
                                     , 426-429. <a href="https://doi.org/10.1134/S1070428012030153" title="DOI URL">https://doi.org/10.1134/S1070428012030153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428012030153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428012030153%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252Breaction%252Bof%252B5%25252C6-dialkyl-2-halopyridine-3%25252C4-dicarbonitriles%252Bwith%252Bammonia%26aulast%3DMaksimova%26aufirst%3DV.%2BN.%26date%3D2012%26date%3D2012%26volume%3D48%26issue%3D3%26spage%3D426%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sylvain  Célanire</span>, <span class="hlFld-ContribAuthor ">Guillaume  Duvey</span>, <span class="hlFld-ContribAuthor ">Sonia  Poli</span>, <span class="hlFld-ContribAuthor ">Jean-Philippe  Rocher</span>. </span><span class="cited-content_cbyCitation_article-title">mGluR2 Activators and mGluR5 Blockers Advancing in the Clinic for Major CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 71-88. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00006-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00006-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00006-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00006-0%26sid%3Dliteratum%253Aachs%26atitle%3DmGluR2%252BActivators%252Band%252BmGluR5%252BBlockers%252BAdvancing%252Bin%252Bthe%252BClinic%252Bfor%252BMajor%252BCNS%252BDisorders%26aulast%3DC%25C3%25A9lanire%26aufirst%3DSylvain%26date%3D2012%26spage%3D71%26epage%3D88%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephan  Urwyler</span>, . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2011,</strong> <em>63 </em>
                                    (1)
                                     , 59-126. <a href="https://doi.org/10.1124/pr.109.002501" title="DOI URL">https://doi.org/10.1124/pr.109.002501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.109.002501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.109.002501%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DAllosteric%252BModulation%252Bof%252BFamily%252BC%252BG-Protein-Coupled%252BReceptors%25253A%252Bfrom%252BMolecular%252BInsights%252Bto%252BTherapeutic%252BPerspectives%26aulast%3DUrwyler%26aufirst%3DStephan%26date%3D2011%26date%3D2011%26volume%3D63%26issue%3D1%26spage%3D59%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of small molecule mGluR5 negative modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of the initial hit <b>5a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) R<sup>1</sup>COOH/EDCI; (b) Dess−Martin periodinane; (c) POCl<sub>3</sub> Δ; (d) H<sub>2</sub>/Pd(OH)<sub>2</sub> or HBr, Δ; (e) R<sup>2</sup>X/DIEA or R<sup>2</sup>X/Pd<sub>2</sub>(dba)<sub>3</sub>/NaO<i>t</i>-Bu</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) benzyl 2-hydrazinyl-2-oxoethylcarbamate/EtOH/Δ; (b) ethyl bromoacetate/KO<i>t</i>-Bu/DMF; (c) H<sub>2</sub>/10%Pd/C/AcOH; (d) BH<sub>3</sub>·THF; (e) 3-bromo-5-fluorobenzonitrile/Pd<sub>2</sub>(dba)<sub>3</sub>/Xantphos/Cs<sub>2</sub>CO<sub>3</sub>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents: (a) Br<sub>2</sub>/DCM; (b) ethyl diazoacetate/BF<sub>3</sub>·Et<sub>2</sub>O; (c) 3N HCl/Δ; (d) NaN<sub>3</sub>/DMF/AcOH; (e) LAH/THF; (f) picolinic acid/EDCI/DCM; (g) Dess−Martin reagent/DCM; (h) Burgess' Reagent, THF, Δ; (i) 48% HBr/Δ; (j) 3-bromo-5-f luorobenzonitrile or 3-bromobenzonitrile/Pd<sub>2</sub>(dba)<sub>3</sub>/NaO<i>t</i>-Bu</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/medium/jm-2010-00736h_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Duration of occupancy of <b>29b</b> in rat following a 3 mpk ip dose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-19/jm100736h/production/images/large/jm-2010-00736h_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100736h&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i61">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31068" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31068" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 22 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="note"><p class="first last">For reviews on metabotropic glutamate receptors, see:</p></div><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schoepp, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monn, J. A.</span><span> </span><span class="NLM_article-title">Pharmacological Agents Acting at Subtypes of Metabotropic Glutamate Receptors</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1431</span><span class="NLM_x">–</span> <span class="NLM_lpage">1476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1016%2FS0028-3908%2899%2900092-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=10530808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADyaK1MXlvVWnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1431-1476&author=D.+D.+Schoeppauthor=D.+E.+Janeauthor=J.+A.+Monn&title=Pharmacological+Agents+Acting+at+Subtypes+of+Metabotropic+Glutamate+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological agents acting at subtypes of metabotropic glutamate receptors</span></div><div class="casAuthors">Schoepp, D. D.; Jane, D. E.; Monn, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1431-1476</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with ∼270 refs.  Metabotropic (G-protein-coupled) glutamate (mGlu) receptors have now emerged as a recognized, but still relatively new area of excitatory amino acid research.  Current understanding of the roles and involvement of mGlu receptor subtypes in physiol./pathophysiol. functions of the central nervous system has been recently propelled by the emergence of various structurally novel, potent, and mGlu receptor selective pharmacol. agents.  This article reviews the evolution of pharmacol. agents that have been reported to target mGlu receptors, with a focus on the known receptor subtype selectivities of current agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1C80nlavsgrVg90H21EOLACvtfcHk0liv6QnCp5hESw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvVWnsLc%253D&md5=08a832c7cab387bc096131bd2d916cab</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2899%2900092-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252899%252900092-1%26sid%3Dliteratum%253Aachs%26aulast%3DSchoepp%26aufirst%3DD.%2BD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonn%26aufirst%3DJ.%2BA.%26atitle%3DPharmacological%2520Agents%2520Acting%2520at%2520Subtypes%2520of%2520Metabotropic%2520Glutamate%2520Receptors%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1431%26epage%3D1476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Niswender, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conn, P. J.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptors: Physiology, Pharmacology and Disease</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=295-322&author=C.+H.+Niswenderauthor=P.+J.+Conn&title=Metabotropic+Glutamate+Receptors%3A+Physiology%2C+Pharmacology+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNiswender%26aufirst%3DC.%2BH.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DMetabotropic%2520Glutamate%2520Receptors%253A%2520Physiology%252C%2520Pharmacology%2520and%2520Disease%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D295%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Chizh, B. A.</span><span> </span><span class="NLM_article-title">Novel Approaches to Targeting Glutamate Receptors for the Treatment of Chronic Pain: Review Article</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=169-176&author=B.+A.+Chizh&title=Novel+Approaches+to+Targeting+Glutamate+Receptors+for+the+Treatment+of+Chronic+Pain%3A+Review+Article"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChizh%26aufirst%3DB.%2BA.%26atitle%3DNovel%2520Approaches%2520to%2520Targeting%2520Glutamate%2520Receptors%2520for%2520the%2520Treatment%2520of%2520Chronic%2520Pain%253A%2520Review%2520Article%26jtitle%3DAmino%2520Acids%26date%3D2002%26volume%3D23%26spage%3D169%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Keywood, C.; Wakefield, M. A</span><span> </span><span class="NLM_article-title">Single-Blind, Placebo-Controlled, Proof of Concept Study of the Effect of the mGluR5 Negative Allosteric Modulator, ADX10059, on 24 h Esophageal pH and Clinical Symptoms, in Patients with Gastroesophageal Reflux Disease (GERD)</span>. Presented at the <span class="NLM_conf-name">Sixth International Meeting on Metabotropic Glutamate Receptors</span>, <span class="NLM_conf-loc">Taormina, Sicily-Italy</span>, <span class="NLM_conf-date">September 14−19, 2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Keywood%2C+C.%3B+Wakefield%2C+M.+A+Single-Blind%2C+Placebo-Controlled%2C+Proof+of+Concept+Study+of+the+Effect+of+the+mGluR5+Negative+Allosteric+Modulator%2C+ADX10059%2C+on+24+h+Esophageal+pH+and+Clinical+Symptoms%2C+in+Patients+with+Gastroesophageal+Reflux+Disease+%28GERD%29.+Presented+at+the+Sixth+International+Meeting+on+Metabotropic+Glutamate+Receptors%2C+Taormina%2C+Sicily-Italy%2C+September+14%E2%88%9219%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKeywood%26aufirst%3DC.%26atitle%3DSingle-Blind%252C%2520Placebo-Controlled%252C%2520Proof%2520of%2520Concept%2520Study%2520of%2520the%2520Effect%2520of%2520the%2520mGluR5%2520Negative%2520Allosteric%2520Modulator%252C%2520ADX10059%252C%2520on%252024%2520h%2520Esophageal%2520pH%2520and%2520Clinical%2520Symptoms%252C%2520in%2520Patients%2520with%2520Gastroesophageal%2520Reflux%2520Disease%2520%2528GERD%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span>Addex Pharmaceuticals Home Page, <a href="http://www.addexpharma.com" class="extLink">http://www.addexpharma.com</a> (accessed June 7,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Addex+Pharmaceuticals+Home+Page%2C+http%3A%2F%2Fwww.addexpharma.com+%28accessed+June+7%2C+2010%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAddex%2520Pharmaceuticals%2520Home%2520Page%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehrani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roppe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bristow, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washburn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span> </span><span class="NLM_article-title">3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: A Potent and Highly Selective Metabotropic Glutamate Subtype 5 Receptor Antagonist with Anxiolytic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">204</span><span class="NLM_x">–</span> <span class="NLM_lpage">206</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm025570j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=204-206&author=N.+D.+P.+Cosfordauthor=L.+Tehraniauthor=J.+Roppeauthor=E.+Schweigerauthor=N.+D.+Smithauthor=J.+Andersonauthor=L.+Bristowauthor=J.+Brodkinauthor=X.+Jiangauthor=I.+McDonaldauthor=S.+Raoauthor=M.+Washburnauthor=M.+A.+Varney&title=3-%5B%282-Methyl-1%2C3-thiazol-4-yl%29ethynyl%5D-pyridine%3A+A+Potent+and+Highly+Selective+Metabotropic+Glutamate+Subtype+5+Receptor+Antagonist+with+Anxiolytic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm025570j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm025570j%26sid%3Dliteratum%253Aachs%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DSchweiger%26aufirst%3DE.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBristow%26aufirst%3DL.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMcDonald%26aufirst%3DI.%26aulast%3DRao%26aufirst%3DS.%26aulast%3DWashburn%26aufirst%3DM.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26atitle%3D3-%255B%25282-Methyl-1%252C3-thiazol-4-yl%2529ethynyl%255D-pyridine%253A%2520A%2520Potent%2520and%2520Highly%2520Selective%2520Metabotropic%2520Glutamate%2520Subtype%25205%2520Receptor%2520Antagonist%2520with%2520Anxiolytic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D204%26epage%3D206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Berg, D.; Trenkwalder, C.; Eggert, K.; Csoti, I.; Storch, A.; Gasparini, F.; Hariry, S.; Johns, D. G.; Gomez-Mancilla, B. A.</span><span> </span><span class="NLM_article-title">Randomized, Controlled Trial Evaluating AFQ056 in Reducing Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease</span>. Presented at the <span class="NLM_conf-name">Movement Disorder Society Conference</span>, <span class="NLM_conf-loc">Paris, France</span>, <span class="NLM_conf-date">June 7−11, 2009</span>;  <span class="NLM_fpage">LB-05</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berg%2C+D.%3B+Trenkwalder%2C+C.%3B+Eggert%2C+K.%3B+Csoti%2C+I.%3B+Storch%2C+A.%3B+Gasparini%2C+F.%3B+Hariry%2C+S.%3B+Johns%2C+D.+G.%3B+Gomez-Mancilla%2C+B.+A.+Randomized%2C+Controlled+Trial+Evaluating+AFQ056+in+Reducing+Levodopa-Induced+Dyskinesia+in+Patients+with+Parkinson%E2%80%99s+Disease.+Presented+at+the+Movement+Disorder+Society+Conference%2C+Paris%2C+France%2C+June+7%E2%88%9211%2C+2009%3B+LB-05."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DD.%26atitle%3DRandomized%252C%2520Controlled%2520Trial%2520Evaluating%2520AFQ056%2520in%2520Reducing%2520Levodopa-Induced%2520Dyskinesia%2520in%2520Patients%2520with%2520Parkinson%25E2%2580%2599s%2520Disease%26spage%3DLB-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingenhöhl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoehr, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flor, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vranesic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biollaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allgeier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckendorn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urwyler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacaan, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santori, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velicelebi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, R.</span><span> </span><span class="NLM_article-title">2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a Potent, Selective and Systemically Active mGluR5 Receptor Antagonist</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1503</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=1493-1503&author=F.+Gaspariniauthor=K.+Lingenh%C3%B6hlauthor=N.+Stoehrauthor=P.+J.+Florauthor=M.+Heinrichauthor=I.+Vranesicauthor=M.+Biollazauthor=H.+Allgeierauthor=R.+Heckendornauthor=S.+Urwylerauthor=M.+A.+Varneyauthor=E.+C.+Johnsonauthor=S.+D.+Hessauthor=S.+P.+Raoauthor=A.+I.+Sacaanauthor=E.+M.+Santoriauthor=G.+Velicelebiauthor=R.+Kuhn&title=2-Methyl-6-%28phenylethynyl%29-pyridine+%28MPEP%29%2C+a+Potent%2C+Selective+and+Systemically+Active+mGluR5+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DLingenh%25C3%25B6hl%26aufirst%3DK.%26aulast%3DStoehr%26aufirst%3DN.%26aulast%3DFlor%26aufirst%3DP.%2BJ.%26aulast%3DHeinrich%26aufirst%3DM.%26aulast%3DVranesic%26aufirst%3DI.%26aulast%3DBiollaz%26aufirst%3DM.%26aulast%3DAllgeier%26aufirst%3DH.%26aulast%3DHeckendorn%26aufirst%3DR.%26aulast%3DUrwyler%26aufirst%3DS.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DE.%2BC.%26aulast%3DHess%26aufirst%3DS.%2BD.%26aulast%3DRao%26aufirst%3DS.%2BP.%26aulast%3DSacaan%26aufirst%3DA.%2BI.%26aulast%3DSantori%26aufirst%3DE.%2BM.%26aulast%3DVelicelebi%26aufirst%3DG.%26aulast%3DKuhn%26aufirst%3DR.%26atitle%3D2-Methyl-6-%2528phenylethynyl%2529-pyridine%2520%2528MPEP%2529%252C%2520a%2520Potent%252C%2520Selective%2520and%2520Systemically%2520Active%2520mGluR5%2520Receptor%2520Antagonist%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D1493%26epage%3D1503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">For recent reviews on small molecule antagonists of mGluR5, see:</p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gasparini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilbe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Mancilla, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">mGluR5 Antagonists: Discovery, Characterization and Drug Development</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=18729017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=655-665&author=F.+Gaspariniauthor=G.+Bilbeauthor=B.+Gomez-Mancillaauthor=W.+Spooren&title=mGluR5+Antagonists%3A+Discovery%2C+Characterization+and+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">mGluR5 antagonists: discovery, characterization and drug development</span></div><div class="casAuthors">Gasparini, Fabrizio; Bilbe, Graeme; Gomez-Mancilla, Baltazar; Spooren, Will</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">655-665</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Disturbances of glutamate-mediated neurotransmission have been implicated in a broad range of nervous system disorders.  Numerous attempts to correct nervous system dysfunction by pharmacol. intervention at glutamate receptors have been made, and some of the approaches have achieved a high level of preclin. validation.  However, in a no. of cases involving agents acting as blockers of the ionotropic glutamate receptors, clin. success could not be achieved, mostly because of the lack of a therapeutic window.  The identification of the metabotropic glutamate receptor (mGluR) family and their modulatory role in the control of neurotransmission provided a new means to alter glutamatergic transmission.  Furthermore, selective agents acting as allosteric antagonists at the mGluR5 subtype have demonstrated therapeutic potential.  The identification and characterization of mGluR5 antagonists and recent progress in clin. development are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox2OH93uxCzbVg90H21EOLACvtfcHk0lizClrKztd4ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2rt7nO&md5=cce30e9f299498315c4d2799f43bf4e3</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26aulast%3DBilbe%26aufirst%3DG.%26aulast%3DGomez-Mancilla%26aufirst%3DB.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DmGluR5%2520Antagonists%253A%2520Discovery%252C%2520Characterization%2520and%2520Drug%2520Development%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D655%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordquist, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span> </span><span class="NLM_article-title">mGluR5 Receptor Antagonists and Their Therapeutic Potential</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1517%2F13543776.18.2.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD1cXitleksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=123-142&author=G.+Jaeschkeauthor=J.+G.+Wettsteinauthor=R.+E.+Nordquistauthor=W.+Spooren&title=mGluR5+Receptor+Antagonists+and+Their+Therapeutic+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">mGlu5 receptor antagonists and their therapeutic potential</span></div><div class="casAuthors">Jaeschke, Georg; Wettstein, Joseph G.; Nordquist, Rebecca E.; Spooren, Will</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-142</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Glutamate mediates its effects via ionotropic and metabotropic glutamate (mGlu) receptors. mGlu receptors are G protein-coupled receptors that are classified into three clusters, group I-III.  This review focuses on the mGlu5 receptors of group I. mGlu5 receptors are highly expressed in limbic brain regions and are located postsynaptically.  Objective: Following the discovery of the prototypical neg. allosteric modulator MPEP, the therapeutic potential of mGlu5 receptors has been steadily explored and expanded.  This review highlights present developments in drug discovery and the therapeutic potential of neg. allosteric modulators.  Methods: Material evaluated ranged from patents to published literature, but also included information that is available from public-accessible websites.  Results/conclusion: Based on the wide and consistent effects of prototypical antagonists, such as MPEP, it is concluded that mGlu5 receptor antagonists have treatment potential for both peripheral and central nervous system disorders ranging from psychiatric, neurol. to neuromuscular, including illnesses with no apparent nervous system link, such as cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqANYNwRmVlq7Vg90H21EOLACvtfcHk0lizClrKztd4ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXitleksro%253D&md5=41d6942174211f8ade65b976021fc637</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1517%2F13543776.18.2.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.18.2.123%26sid%3Dliteratum%253Aachs%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26aulast%3DNordquist%26aufirst%3DR.%2BE.%26aulast%3DSpooren%26aufirst%3DW.%26atitle%3DmGluR5%2520Receptor%2520Antagonists%2520and%2520Their%2520Therapeutic%2520Potential%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2008%26volume%3D18%26spage%3D123%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rodriquez, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R.</span><span> </span><span class="NLM_article-title">Recent Progress in the Development of Allosteric Modulators of mGluR5</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">715</span><span class="NLM_x">–</span> <span class="NLM_lpage">722</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=715-722&author=A.+L.+Rodriquezauthor=R.+Williams&title=Recent+Progress+in+the+Development+of+Allosteric+Modulators+of+mGluR5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodriquez%26aufirst%3DA.%2BL.%26aulast%3DWilliams%26aufirst%3DR.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Development%2520of%2520Allosteric%2520Modulators%2520of%2520mGluR5%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D715%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Bach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slassi, A.</span><span> </span><span class="NLM_article-title">Metabotropic Glutamate Receptor 5 Modulators and Their Potential Therapeutic Applications</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1517%2F13543776.17.4.371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkt1ertLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=371-384&author=P.+Bachauthor=M.+Isaacauthor=A.+Slassi&title=Metabotropic+Glutamate+Receptor+5+Modulators+and+Their+Potential+Therapeutic+Applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Metabotropic glutamate receptor 5 modulators and their potential therapeutic applications</span></div><div class="casAuthors">Bach, Peter; Isaac, Methvin; Slassi, Abdelmalik</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">371-384</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Extensive research into the functions of glutamate and glutamate receptors in the CNS has shown an essential role of metabotropic glutamate (mGlu) receptors not only in normal brain functions but also in neurol. and psychiatric disorders.  The precise functions of these receptors remain undefined and progress toward understanding their functions had been hampered by the lack of selective ligands with appropriate pharmacokinetic properties.  The Group I mGlu receptors, comprising mGlu1 and mGlu5 receptors, are well positioned to regulate and fine-tune neuronal excitability and synaptic transmission through its modulation of various signal transduction pathways and interactions with other transmitter systems.  Therefore, the mGlu5 receptor may be an important therapeutic target for the treatment of disorders of the CNS.  The discovery of MPEP, a non-competitive mGluR5 antagonist, provided a potent, selective, systemically active tool compd. for proof-of-concept studies in animal models of various disease states.  Considerable advances have been made since the applications of glutamate receptor modulators was reviewed by Sabbatini and Micheli in this journal in late 2004.  Most intriguing is the increased understanding of the mechanism and pathophysiol. of mGlu5 receptors in the treatment of CNS diseases.  The importance of mGlu5 receptors is manifested by the growing nos. of patents filed and scientific papers published in recent years.  In the present patent review, compd. series have been categorized as antagonists/inhibitors or modulators/potentiators, according to the claims in the resp. patent applications.  Claims that relate to and specify group I mGluRs have been included in a sep. section, while claims for specified compd. series for the treatment of glutamate receptor-mediated disorders in general have not been included.  Primary literature has been referenced when information on compd. series from the patent literature could be supplemented with, for example, SAR or pharmacol. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsQia1cTnEobVg90H21EOLACvtfcHk0lizClrKztd4ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkt1ertLs%253D&md5=ddf617b337a327bc5ee933d88bfc83eb</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.4.371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.4.371%26sid%3Dliteratum%253Aachs%26aulast%3DBach%26aufirst%3DP.%26aulast%3DIsaac%26aufirst%3DM.%26aulast%3DSlassi%26aufirst%3DA.%26atitle%3DMetabotropic%2520Glutamate%2520Receptor%25205%2520Modulators%2520and%2520Their%2520Potential%2520Therapeutic%2520Applications%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2007%26volume%3D17%26spage%3D371%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Pecknold, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appeltauer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrzesinski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allan, T.</span><span> </span><span class="NLM_article-title">Treatment of Anxiety Using Fenobam (a Nonbenzodiazepine) in a Double-Blind Standard (Diazepam) Placebo-Controlled Study</span> <span class="citation_source-journal">J. Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A280%3ADyaL387ptVCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1982&pages=129-133&author=J.+C.+Pecknoldauthor=D.+J.+McClureauthor=L.+Appeltauerauthor=L.+Wrzesinskiauthor=T.+Allan&title=Treatment+of+Anxiety+Using+Fenobam+%28a+Nonbenzodiazepine%29+in+a+Double-Blind+Standard+%28Diazepam%29+Placebo-Controlled+Study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study</span></div><div class="casAuthors">Pecknold J C; McClure D J; Appeltauer L; Wrzesinski L; Allan T</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical psychopharmacology</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">129-33</span>
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLFJ-67ZItf4NpW7w2tapOfW6udTcc2ebeEH1TaMFwJ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL387ptVCqtA%253D%253D&md5=500b6039321f24462ab3fd1985560fea</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPecknold%26aufirst%3DJ.%2BC.%26aulast%3DMcClure%26aufirst%3DD.%2BJ.%26aulast%3DAppeltauer%26aufirst%3DL.%26aulast%3DWrzesinski%26aufirst%3DL.%26aulast%3DAllan%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520Anxiety%2520Using%2520Fenobam%2520%2528a%2520Nonbenzodiazepine%2529%2520in%2520a%2520Double-Blind%2520Standard%2520%2528Diazepam%2529%2520Placebo-Controlled%2520Study%26jtitle%3DJ.%2520Clin.%2520Neuropharmacol.%26date%3D1982%26volume%3D2%26spage%3D129%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Porter, R. H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Büttelmann, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolczewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, J.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinssen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wichmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mühlemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gatti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutel, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenobam, A</span><span> </span><span class="NLM_article-title">Clinically Validated Nonbenzodiazepine Anxiolytic is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">721</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1124%2Fjpet.105.089839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=16040814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=711-721&author=R.+H.+P.+Porterauthor=G.+Jaeschkeauthor=W.+Spoorenauthor=T.+M.+Ballardauthor=B.+B%C3%BCttelmannauthor=S.+Kolczewskiauthor=J.-U.+Petersauthor=E.+Prinssenauthor=J.+Wichmannauthor=E.+Vieiraauthor=A.+M%C3%BChlemannauthor=S.+Gattiauthor=V.+Mutelauthor=P.+Malherbeauthor=A+Fenobam&title=Clinically+Validated+Nonbenzodiazepine+Anxiolytic+is+a+Potent%2C+Selective%2C+and+Noncompetitive+mGlu5+Receptor+Antagonist+with+Inverse+Agonist+Activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fenobam: A clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity</span></div><div class="casAuthors">Porter, Richard H. P.; Jaeschke, Georg; Spooren, Will; Ballard, Theresa M.; Buttelmann, Bernd; Kolczewski, Sabine; Peters, Jens-Uwe; Prinseen, Eric; Wichmann, Jurgen; Vieira, Eric; Muhlemann, Andreas; Gatti, Silvia; Mutel, Vincent; Malherbe, Pari</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">711-721</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Fenobam [N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazole-2-yl)urea] is an atypical anxiolytic agent with unknown mol. target that has previously been demonstrated both in rodents and human to exert anxiolytic activity.  Here, we report that fenobam is a selective and potent metabotropic glutamate (mGlu)5 receptor antagonist acting at an allosteric modulatory site shared with 2-methyl-6-phenylethynyl-pyridine (MPEP), the protypical selective mGlu5 receptor antagonist.  Fenobam inhibited quisqualate-evoked intracellular calcium response mediated by human mGlu5 receptor with IC50 = 58±2 nM.  It acted in a noncompetitive manner, similar to MPEP and demonstrated inverse agonist properties, blocking 66% of the mGlu5 receptor basal activity (in an over expressed cell line) with an IC50 = 84±13 nM.  [3H]Fenobam bound to rat and human recombinant receptors with Kd values of 54±6 and 31±4 nM, resp.  MPEP inhibited [3H]fenobam binding to human mGlu5 receptors with a Ki value of 6.7±0.7 nM, indicating a common binding site shared by both allosteric antagonists.  Fenobam exhibits anxiolytic activity in the stress-induced hyperthermia model, Vogel conflict test, Geller-Seifter conflict test, and conditioned emotional response with a min. ED of 10 to 30 mg/kg p.o.  Furthermore, fenobam is devoid of GABAergic activity, confirming previous reports that fenobam acts by a mechanism distinct from benzodiazepines.  The non-GABAergic activity of fenobam, coupled with its robust anxiolytic activity and reported efficacy in human in a double blind placebo-controlled trial, supports the potential of developing mGlu5 receptor antagonists with an improved therapeutic window over benzodiazepines as novel anxiolytic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQg1qRiOD0cLVg90H21EOLACvtfcHk0lgC8RLwqtw5Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyhtr7F&md5=8d08eb1e3f777231204024da12301a2e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089839%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DSpooren%26aufirst%3DW.%26aulast%3DBallard%26aufirst%3DT.%2BM.%26aulast%3DB%25C3%25BCttelmann%26aufirst%3DB.%26aulast%3DKolczewski%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DJ.-U.%26aulast%3DPrinssen%26aufirst%3DE.%26aulast%3DWichmann%26aufirst%3DJ.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DM%25C3%25BChlemann%26aufirst%3DA.%26aulast%3DGatti%26aufirst%3DS.%26aulast%3DMutel%26aufirst%3DV.%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DFenobam%26aufirst%3DA%26atitle%3DClinically%2520Validated%2520Nonbenzodiazepine%2520Anxiolytic%2520is%2520a%2520Potent%252C%2520Selective%252C%2520and%2520Noncompetitive%2520mGlu5%2520Receptor%2520Antagonist%2520with%2520Inverse%2520Agonist%2520Activity%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D711%26epage%3D721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gasparini, F.; Auberson, Y.; Ofner, S.</span><span> </span><span class="NLM_article-title">Acetylene Derivatives Having mGluR5 Antagonistic Activity</span>. Patent PCT/WO03/047581A1,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=F.+Gasparini&author=Y.+Auberson&author=S.+Ofner&title=Acetylene+Derivatives+Having+mGluR5+Antagonistic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DF.%26atitle%3DAcetylene%2520Derivatives%2520Having%2520mGluR5%2520Antagonistic%2520Activity%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Roppe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehrani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosford, N. D. P.</span><span> </span><span class="NLM_article-title">Discovery of Novel Heteroarylazoles that are Metabotropic Glutamate Subtype 5 Receptor Antagonists with Anxiolytic Activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4645</span><span class="NLM_x">–</span> <span class="NLM_lpage">4648</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049828c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4645-4648&author=J.+Roppeauthor=N.+D.+Smithauthor=D.+Huangauthor=L.+Tehraniauthor=B.+Wangauthor=J.+Andersonauthor=J.+Brodkinauthor=J.+Chungauthor=X.+Jiangauthor=C.+Kingauthor=B.+Munozauthor=M.+A.+Varneyauthor=P.+Prasitauthor=N.+D.+P.+Cosford&title=Discovery+of+Novel+Heteroarylazoles+that+are+Metabotropic+Glutamate+Subtype+5+Receptor+Antagonists+with+Anxiolytic+Activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm049828c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049828c%26sid%3Dliteratum%253Aachs%26aulast%3DRoppe%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DN.%2BD.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DTehrani%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DAnderson%26aufirst%3DJ.%26aulast%3DBrodkin%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DKing%26aufirst%3DC.%26aulast%3DMunoz%26aufirst%3DB.%26aulast%3DVarney%26aufirst%3DM.%2BA.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DCosford%26aufirst%3DN.%2BD.%2BP.%26atitle%3DDiscovery%2520of%2520Novel%2520Heteroarylazoles%2520that%2520are%2520Metabotropic%2520Glutamate%2520Subtype%25205%2520Receptor%2520Antagonists%2520with%2520Anxiolytic%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4645%26epage%3D4648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hall, S. E.; Ballas, L. M.; Kulanthaivel, P.; Boros, C.; Jiang, J. B.; Jagdmann, G. E.,  Jr.; Lai, Y.-S.; Biggers, C. K.; Hu, H.; Hallock, Y.; Hughes, P. F.; Defauw, J. M.; Lynch, M. P.; Lampe, J. W. C.; Menaldino, D. S.; Heerding, J. M.; Janzen, W. P.; Hollinshead, S. P.</span> Balanoids. Patent PCT/WO94/20062A2<span class="NLM_x"> </span><span class="NLM_year">1994</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hall%2C+S.+E.%3B+Ballas%2C+L.+M.%3B+Kulanthaivel%2C+P.%3B+Boros%2C+C.%3B+Jiang%2C+J.+B.%3B+Jagdmann%2C+G.+E.%2C+Jr.%3B+Lai%2C+Y.-S.%3B+Biggers%2C+C.+K.%3B+Hu%2C+H.%3B+Hallock%2C+Y.%3B+Hughes%2C+P.+F.%3B+Defauw%2C+J.+M.%3B+Lynch%2C+M.+P.%3B+Lampe%2C+J.+W.+C.%3B+Menaldino%2C+D.+S.%3B+Heerding%2C+J.+M.%3B+Janzen%2C+W.+P.%3B+Hollinshead%2C+S.+P.+Balanoids.+Patent+PCT%2FWO94%2F20062A2+1994."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DS.%2BE.%26date%3D1994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Lai, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mylott, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span> </span><span class="NLM_article-title">Ring Size Effects in the PKC Inhibitory Activities of Perhydroazepine Analogs of Balanol</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">2151</span><span class="NLM_x">–</span> <span class="NLM_lpage">2154</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1995&pages=2151-2154&author=Y.-S.+Laiauthor=D.+S.+Menaldinoauthor=J.+B.+Nicholsauthor=G.+E.+Jagdmannauthor=F.+Mylottauthor=J.+Gillespieauthor=S.+E.+Hall&title=Ring+Size+Effects+in+the+PKC+Inhibitory+Activities+of+Perhydroazepine+Analogs+of+Balanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.-S.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DNichols%26aufirst%3DJ.%2BB.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DMylott%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DS.%2BE.%26atitle%3DRing%2520Size%2520Effects%2520in%2520the%2520PKC%2520Inhibitory%2520Activities%2520of%2520Perhydroazepine%2520Analogs%2520of%2520Balanol%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1995%26volume%3D5%26spage%3D2151%26epage%3D2154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ashton, W. T.; Caldwell, C. G.; Mathvink, R. J.; Ok, H. O.; Reigle, L. B.; Weber, A. E.</span><span> </span><span class="NLM_article-title">Preparation of 3-Amino-4-phenylbutanoic acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes</span>. Patent PCT/WO2004/064778A2<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+T.+Ashton&author=C.+G.+Caldwell&author=R.+J.+Mathvink&author=H.+O.+Ok&author=L.+B.+Reigle&author=A.+E.+Weber&title=Preparation+of+3-Amino-4-phenylbutanoic+acid+Derivatives+as+Dipeptidyl+Peptidase+Inhibitors+for+the+Treatment+or+Prevention+of+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAshton%26aufirst%3DW.%2BT.%26atitle%3DPreparation%2520of%25203-Amino-4-phenylbutanoic%2520acid%2520Derivatives%2520as%2520Dipeptidyl%2520Peptidase%2520Inhibitors%2520for%2520the%2520Treatment%2520or%2520Prevention%2520of%2520Diabetes%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gordon, T. B.; Morgan, B. A.</span><span> </span><span class="NLM_article-title">Prenyl Transferase Inhibitors</span>. Patent PCT/WO2000/039130A2<span class="NLM_x"> </span><span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=T.+B.+Gordon&author=B.+A.+Morgan&title=Prenyl+Transferase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DT.%2BB.%26atitle%3DPrenyl%2520Transferase%2520Inhibitors%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikugawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, S.-I.</span><span> </span><span class="NLM_article-title">Chemistry of Diborane and Sodium Borohydride. VIII. Imidate Formation from Nitriles with Sodium Borohydride</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1973&pages=465-472&author=H.+Watanabeauthor=Y.+Kikugawaauthor=S.-I.+Yamada&title=Chemistry+of+Diborane+and+Sodium+Borohydride.+VIII.+Imidate+Formation+from+Nitriles+with+Sodium+Borohydride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKikugawa%26aufirst%3DY.%26aulast%3DYamada%26aufirst%3DS.-I.%26atitle%3DChemistry%2520of%2520Diborane%2520and%2520Sodium%2520Borohydride.%2520VIII.%2520Imidate%2520Formation%2520from%2520Nitriles%2520with%2520Sodium%2520Borohydride%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1973%26volume%3D21%26spage%3D465%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Borchardt, A. J.; Kahraman, M.; Cook, T. G.; Davis, R. L.; Gardiner, E. M. M.; Malecha, J. W.; Noble, S. A.; Prins, T. J.; Sertic, M.; Siegel, D. L.</span><span> </span><span class="NLM_article-title">Heteroaryl Inhibitors of Rho Kinase</span>. Patent PCT/WO2008/011557A2<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+J.+Borchardt&author=M.+Kahraman&author=T.+G.+Cook&author=R.+L.+Davis&author=E.+M.+M.+Gardiner&author=J.+W.+Malecha&author=S.+A.+Noble&author=T.+J.+Prins&author=M.+Sertic&author=D.+L.+Siegel&title=Heteroaryl+Inhibitors+of+Rho+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBorchardt%26aufirst%3DA.%2BJ.%26atitle%3DHeteroaryl%2520Inhibitors%2520of%2520Rho%2520Kinase%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lai, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagdmann, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menaldino, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggers, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janzen, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, L. M.</span><span> </span><span class="NLM_article-title">Synthesis and Protein Kinase C Inhibitory Activities of Balanol Analogs with Replacement of the Perhydroazepine Moiety</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm960497g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=226-235&author=Y.-S.+Laiauthor=J.+S.+Mendozaauthor=G.+E.+Jagdmannauthor=D.+S.+Menaldinoauthor=C.+K.+Biggersauthor=J.+M.+Heerdingauthor=J.+W.+Wilsonauthor=S.+E.+Hallauthor=J.+B.+Jiangauthor=W.+P.+Janzenauthor=L.+M.+Ballas&title=Synthesis+and+Protein+Kinase+C+Inhibitory+Activities+of+Balanol+Analogs+with+Replacement+of+the+Perhydroazepine+Moiety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm960497g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960497g%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DY.-S.%26aulast%3DMendoza%26aufirst%3DJ.%2BS.%26aulast%3DJagdmann%26aufirst%3DG.%2BE.%26aulast%3DMenaldino%26aufirst%3DD.%2BS.%26aulast%3DBiggers%26aufirst%3DC.%2BK.%26aulast%3DHeerding%26aufirst%3DJ.%2BM.%26aulast%3DWilson%26aufirst%3DJ.%2BW.%26aulast%3DHall%26aufirst%3DS.%2BE.%26aulast%3DJiang%26aufirst%3DJ.%2BB.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DBallas%26aufirst%3DL.%2BM.%26atitle%3DSynthesis%2520and%2520Protein%2520Kinase%2520C%2520Inhibitory%2520Activities%2520of%2520Balanol%2520Analogs%2520with%2520Replacement%2520of%2520the%2520Perhydroazepine%2520Moiety%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D226%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Dupriez, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Poul, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgeon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Detheux, M.</span><span> </span><span class="NLM_article-title">Aequorin-Based Functional Assays for G-Protein-Coupled Receptors, Ion Channels, and Tyrosine Kinase Receptors</span> <span class="citation_source-journal">Recept. Channels</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">319</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1080%2F10606820214646" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=12690959" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVCrsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=319-330&author=V.+J.+Dupriezauthor=K.+Maesauthor=E.+Le+Poulauthor=E.+Burgeonauthor=M.+Detheux&title=Aequorin-Based+Functional+Assays+for+G-Protein-Coupled+Receptors%2C+Ion+Channels%2C+and+Tyrosine+Kinase+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aequorin-based functional assays for G-protein-coupled receptors, ion channels and tyrosine kinase receptors</span></div><div class="casAuthors">Dupriez, Vincent J.; Maes, Karlien; Le Poul, Emmanuel; Burgeon, Emmanuel; Detheux, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Receptors and Channels</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">319-330</span>CODEN:
                <span class="NLM_cas:coden">RCHAE4</span>;
        ISSN:<span class="NLM_cas:issn">1060-6823</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Aequorin is a photoprotein originating from jellyfish, whose luminescent activity is dependent on the concn. of calcium ions.  Due to the high sensitivity and low background linked to luminescent assays, as well as to its absence of toxicity and its large linear dynamic range, aequorin has been used as an intracellular calcium indicator since its discovery in the early 1960s.  The first applications of aequorin involved its microinjection in cells.  The cloning of its gene in 1985 opened the way to the stable expression of aequorin in cell lines or even entire organisms.  Here the authors present the validation of aequorin as a functional assay for the screening of G-protein-coupled receptors, ion channels, and tyrosine kinase receptors, as well as for their pharmacol. characterization in agonist and antagonist detection assays.  The authors optimized the authors' cell suspension-based assay and detd. that the most sensitive assay was performed at room temp., with mitochondrially expressed aequorin and using coelenterazine deriv. h for reconstitution of aequorin.  The robustness of the assay and the current availability of luminometers with integrated injectors allow aequorin to fit perfectly with high throughput functional assays requirements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrceQj9SnumELVg90H21EOLACvtfcHk0ljSe8Q8JDMIBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVCrsLg%253D&md5=341940fbd1b156099223fc5de42debeb</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1080%2F10606820214646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10606820214646%26sid%3Dliteratum%253Aachs%26aulast%3DDupriez%26aufirst%3DV.%2BJ.%26aulast%3DMaes%26aufirst%3DK.%26aulast%3DLe%2BPoul%26aufirst%3DE.%26aulast%3DBurgeon%26aufirst%3DE.%26aulast%3DDetheux%26aufirst%3DM.%26atitle%3DAequorin-Based%2520Functional%2520Assays%2520for%2520G-Protein-Coupled%2520Receptors%252C%2520Ion%2520Channels%252C%2520and%2520Tyrosine%2520Kinase%2520Receptors%26jtitle%3DRecept.%2520Channels%26date%3D2002%26volume%3D8%26spage%3D319%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Malherbe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochvil, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muhlemann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zenner, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerber, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeschke, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R. H. P.</span><span> </span><span class="NLM_article-title">Comparison of the Binding Pockets of Two Chemically Unrelated Allosteric Antagonists of the mGluR5 Receptor and Identification of Crucial Resudues Involved in the Inverse Agonism of MPEP</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm100736h&amp;key=10.1111%2Fj.1471-4159.2006.03886.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm100736h&amp;key=16805850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm100736h&amp;key=1%3ACAS%3A528%3ADC%252BD28Xot1Omsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=601-615&author=P.+Malherbeauthor=N.+Kratochvilauthor=A.+Muhlemannauthor=M.-T.+Zennerauthor=C.+Fischerauthor=M.+Stahlauthor=P.+R.+Gerberauthor=G.+Jaeschkeauthor=R.+H.+P.+Porter&title=Comparison+of+the+Binding+Pockets+of+Two+Chemically+Unrelated+Allosteric+Antagonists+of+the+mGluR5+Receptor+and+Identification+of+Crucial+Resudues+Involved+in+the+Inverse+Agonism+of+MPEP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP</span></div><div class="casAuthors">Malherbe, Pari; Kratochwil, Nicole; Muhlemann, Andreas; Zenner, Marie-Therese; Fischer, Christophe; Stahl, Martin; Gerber, Paul R.; Jaeschke, Georg; Porter, Richard H. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">601-615</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Fenobam, a clin. validated non-benzodiazepine anxiolytic, has been shown to be a potent and non-competitive metabotropic glutamate (mGlu)-5 receptor antagonist.  In the present study, we have used the site-directed mutagenesis coupled with three-dimensional receptor-based pharmacophore modeling to elucidate the interacting mode of fenobam within the seven-transmembrane domain (7TMD) of mGlu5 receptor and its comparison with that of 2-methyl-6-(phenylethynyl)pyridine (MPEP), the prototype antagonist.  The common residues involved in the recognition of MPEP and fenobam include Pro6543.36, Tyr6583.40, Thr7806.44, Trp7846.48, Phe7876.51, Tyr7916.55 and Ala8097.47.  The differentiating residues between both modulators' interacting modes are Arg6473.29, Ser6573.39 and Leu7435.47.  Our data suggest that these chem. unrelated mGlu5 antagonists act similarly, probing a functionally unique region of the 7TMD.  Using [3H]inositol phosphates accumulation assay, we have also identified the crit. residues involved in the inverse agonist effect of MPEP.  The mutation W7846.48A completely blocked the inverse agonist activity of MPEP; two mutations F7876.51A and Y7916.55A, caused a drastic decrease in the MPEP inverse agonism.  Furthermore, these three mutations led to an increased efficacy of quisqualate without having any effect on its potency.  The fact that the residues Trp7846.48 and Phe7876.51 are essential equally in antagonism and inverse agonism effects emphasizes again the key role of these residues and the involvement of a common transmembrane network in receptor inactivation by MPEP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwIir19e3p67Vg90H21EOLACvtfcHk0liWmjDXKAxCuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xot1Omsbw%253D&md5=18ddced8d4d9840427a0c529773dd8a9</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03886.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03886.x%26sid%3Dliteratum%253Aachs%26aulast%3DMalherbe%26aufirst%3DP.%26aulast%3DKratochvil%26aufirst%3DN.%26aulast%3DMuhlemann%26aufirst%3DA.%26aulast%3DZenner%26aufirst%3DM.-T.%26aulast%3DFischer%26aufirst%3DC.%26aulast%3DStahl%26aufirst%3DM.%26aulast%3DGerber%26aufirst%3DP.%2BR.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DPorter%26aufirst%3DR.%2BH.%2BP.%26atitle%3DComparison%2520of%2520the%2520Binding%2520Pockets%2520of%2520Two%2520Chemically%2520Unrelated%2520Allosteric%2520Antagonists%2520of%2520the%2520mGluR5%2520Receptor%2520and%2520Identification%2520of%2520Crucial%2520Resudues%2520Involved%2520in%2520the%2520Inverse%2520Agonism%2520of%2520MPEP%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D98%26spage%3D601%26epage%3D615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Johnston, M. J.; Fox, S. H.; McIldowie, M. J.; Piggott, M. J.; Brotchie, J. M.</span><span> </span><span class="NLM_article-title">Antidyskinetic Effects of the Selective Metabotropic Glutamate Receptor 5 (mGluR5) Antagonist MTEP in the MPTP-lesioned Macaque Model of Parkinson’s Disease</span>. Presented at the <span class="NLM_conf-name">Society for Neuroscience Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">October 17−21, 2009</span>;  <span class="NLM_fpage">530.19</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Johnston%2C+M.+J.%3B+Fox%2C+S.+H.%3B+McIldowie%2C+M.+J.%3B+Piggott%2C+M.+J.%3B+Brotchie%2C+J.+M.+Antidyskinetic+Effects+of+the+Selective+Metabotropic+Glutamate+Receptor+5+%28mGluR5%29+Antagonist+MTEP+in+the+MPTP-lesioned+Macaque+Model+of+Parkinson%E2%80%99s+Disease.+Presented+at+the+Society+for+Neuroscience+Meeting%2C+Chicago%2C+IL%2C+October+17%E2%88%9221%2C+2009%3B+530.19."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DJohnston%26aufirst%3DM.%2BJ.%26atitle%3DAntidyskinetic%2520Effects%2520of%2520the%2520Selective%2520Metabotropic%2520Glutamate%2520Receptor%25205%2520%2528mGluR5%2529%2520Antagonist%2520MTEP%2520in%2520the%2520MPTP-lesioned%2520Macaque%2520Model%2520of%2520Parkinson%25E2%2580%2599s%2520Disease%26spage%3D530.19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i60"><a href="/doi/suppl/10.1021/jm100736h">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_56743"></div></div></div></div></div><hr /></hr><p class="last">Detailed synthetic schemes for the preparation of <b>11c</b>, <b>11d</b>, <b>11h</b>, <b>11k</b>, <b>12b</b>, <b>13</b>, <b>14</b>, and <b>21</b>. Results from receptor panel screening (Cerep) for <b>5k</b> and <b>29b</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100736h/suppl_file/jm100736h_si_001.pdf">jm100736h_si_001.pdf (247.53 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100736h&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-19%3Barticle%3Aarticle%3A10.1021%2Fjm100736h%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100736h" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799335ac8d6d18f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
